TTK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O14979 | T165 | Sugiyama | HNRNPDL HNRPDL JKTBP | QDDGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVT |
| O60566 | S1043 | EPSD|PSP | BUB1B BUBR1 MAD3L SSK1 | FDTTFQSHLNKALWKVGKLtsPGALLFQ_____________ |
| O60566 | S435 | EPSD|PSP | BUB1B BUBR1 MAD3L SSK1 | IRAEVFRKKLKEQREAELLtsAEKRAEMQKQIEEMEKKLKE |
| O60566 | S543 | EPSD|PSP | BUB1B BUBR1 MAD3L SSK1 | GPsVPFSIFDEFLLSEKKNKsPPADPPRVLAQRRPLAVLKt |
| O60566 | S670 | EPSD|PSP | BUB1B BUBR1 MAD3L SSK1 | EDQQTACGtIysQtLsIKKLsPIIEDsREAtHSsGFsGSSA |
| O96017 | T68 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | NSsQSSHSSSGTLSsLETVStQELYsIPEDQEPEDQEPEEP |
| P00519 | T735 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ABL1 ABL JTK7 | RsCsAsCVPHGAKDTEWRSVtLPRDLQStGRQFDSstFGGH |
| P04637 | T18 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | TP53 P53 | ___MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P07900 | T115 | EPSD|PSP | HSP90AA1 HSP90A HSPC1 HSPCA | GIGMTKADLINNLGtIAKSGtKAFMEALQAGADISMIGQFG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | S928 | SIGNOR|PSP | MAP4 | PTSAKPssttPRLSRLAtNtsAPDLKNVRsKVGstENIKHQ |
| P27816 | T927 | SIGNOR|PSP | MAP4 | KPTSAKPssttPRLSRLAtNtsAPDLKNVRsKVGstENIKH |
| P30305 | S169 | ELM | CDC25B CDC25HU2 | FQsMPVRLLGHsPVLRNItNsQAPDGRRKsEAGSGAAssSG |
| P30305 | S323 | ELM | CDC25B CDC25HU2 | KEEEKDLVMYSKCQRLFRsPsMPCSVIRPILKRLERPQDRD |
| P33981 | S15 | EPSD|PSP|Sugiyama | TTK MPS1 MPS1L1 | ______MESEDLsGRELtIDsIMNKVRDIKNKFKNEDLtDE |
| P33981 | S214 | SIGNOR | TTK MPS1 MPS1L1 | LLSEEEKKNLSASTVLtAQEsFSGSLGHLQNRNNSCDSRGQ |
| P33981 | S321 | SIGNOR|PSP|Sugiyama | TTK MPS1 MPS1L1 | TSRSECRDLVVPGSKPsGNDsCELRNLKSVQNsHFKEPLVS |
| P33981 | S362 | SIGNOR|EPSD|PSP | TTK MPS1 MPS1L1 | DEKsSELIITDSITLKNKtEssLLAKLEEtKEyQEPEVPEs |
| P33981 | S363 | SIGNOR|EPSD|PSP | TTK MPS1 MPS1L1 | EKsSELIITDSITLKNKtEssLLAKLEEtKEyQEPEVPEsN |
| P33981 | S37 | SIGNOR|EPSD|PSP|Sugiyama | TTK MPS1 MPS1L1 | MNKVRDIKNKFKNEDLtDELsLNKIsADttDNsGtVNQIMM |
| P33981 | S436 | EPSD|PSP | TTK MPS1 MPS1L1 | VNTEQKHTTFEQPVFSVSKQsPPISTSKWFDPKSICKtPss |
| P33981 | S49 | PSP | TTK MPS1 MPS1L1 | NEDLtDELsLNKIsADttDNsGtVNQIMMMANNPEDWLSLL |
| P33981 | S582 | SIGNOR|EPSD|PSP | TTK MPS1 MPS1L1 | NQtLDSYRNEIAYLNKLQQHsDKIIRLYDYEItDQYIYMVM |
| P33981 | S677 | SIGNOR|EPSD|PSP | TTK MPS1 MPS1L1 | DGMLKLIDFGIANQMQPDttsVVKDSQVGtVNYMPPEAIKD |
| P33981 | S7 | PSP | TTK MPS1 MPS1L1 | ______________MESEDLsGRELtIDsIMNKVRDIKNKF |
| P33981 | S742 | SIGNOR|EPSD|PSP | TTK MPS1 MPS1L1 | CILYYMTYGKTPFQQIINQIsKLHAIIDPNHEIEFPDIPEK |
| P33981 | S80 | EPSD|PSP|Sugiyama | TTK MPS1 MPS1L1 | NNPEDWLSLLLKLEKNSVPLsDALLNKLIGRYSQAIEALPP |
| P33981 | S821 | EPSD|PSP | TTK MPS1 MPS1L1 | MAKGttEEMKyVLGQLVGLNsPNsILKAAKTLyEHYsGGES |
| P33981 | S824 | EPSD|PSP | TTK MPS1 MPS1L1 | GttEEMKyVLGQLVGLNsPNsILKAAKTLyEHYsGGESHNs |
| P33981 | S844 | Sugiyama | TTK MPS1 MPS1L1 | sILKAAKTLyEHYsGGESHNssssKtFEKKRGKK_______ |
| P33981 | S845 | EPSD|PSP | TTK MPS1 MPS1L1 | ILKAAKTLyEHYsGGESHNssssKtFEKKRGKK________ |
| P33981 | S847 | EPSD|PSP | TTK MPS1 MPS1L1 | KAAKTLyEHYsGGESHNssssKtFEKKRGKK__________ |
| P33981 | T12 | SIGNOR|EPSD|PSP|Sugiyama | TTK MPS1 MPS1L1 | _________MESEDLsGRELtIDsIMNKVRDIKNKFKNEDL |
| P33981 | T288 | EPSD|PSP | TTK MPS1 MPS1L1 | SCPFGRVPVNLLNsPDCDVKtDDsVVPCFMKRQTSRSECRD |
| P33981 | T33 | SIGNOR|EPSD|PSP|Sugiyama | TTK MPS1 MPS1L1 | IDsIMNKVRDIKNKFKNEDLtDELsLNKIsADttDNsGtVN |
| P33981 | T360 | EPSD|PSP | TTK MPS1 MPS1L1 | VSDEKsSELIITDSITLKNKtEssLLAKLEEtKEyQEPEVP |
| P33981 | T371 | SIGNOR|PSP | TTK MPS1 MPS1L1 | TDSITLKNKtEssLLAKLEEtKEyQEPEVPEsNQKQWQSKR |
| P33981 | T45 | PSP | TTK MPS1 MPS1L1 | NKFKNEDLtDELsLNKIsADttDNsGtVNQIMMMANNPEDW |
| P33981 | T46 | PSP | TTK MPS1 MPS1L1 | KFKNEDLtDELsLNKIsADttDNsGtVNQIMMMANNPEDWL |
| P33981 | T564 | SIGNOR|EPSD|PSP | TTK MPS1 MPS1L1 | NEKKQIYAIKYVNLEEADNQtLDSYRNEIAYLNKLQQHsDK |
| P33981 | T675 | SIGNOR|EPSD|PSP | TTK MPS1 MPS1L1 | IVDGMLKLIDFGIANQMQPDttsVVKDSQVGtVNYMPPEAI |
| P33981 | T676 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TTK MPS1 MPS1L1 | VDGMLKLIDFGIANQMQPDttsVVKDSQVGtVNYMPPEAIK |
| P33981 | T686 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TTK MPS1 MPS1L1 | GIANQMQPDttsVVKDSQVGtVNYMPPEAIKDMSSSRENGK |
| P33981 | T795 | EPSD|PSP | TTK MPS1 MPS1L1 | DPKQRISIPELLAHPYVQIQtHPVNQMAKGttEEMKyVLGQ |
| P33981 | T805 | EPSD|PSP | TTK MPS1 MPS1L1 | LLAHPYVQIQtHPVNQMAKGttEEMKyVLGQLVGLNsPNsI |
| P33981 | T806 | SIGNOR|EPSD|PSP | TTK MPS1 MPS1L1 | LAHPYVQIQtHPVNQMAKGttEEMKyVLGQLVGLNsPNsIL |
| P33981 | T849 | EPSD|PSP | TTK MPS1 MPS1L1 | AKTLyEHYsGGESHNssssKtFEKKRGKK____________ |
| P33981 | Y811 | EPSD|PSP | TTK MPS1 MPS1L1 | VQIQtHPVNQMAKGttEEMKyVLGQLVGLNsPNsILKAAKT |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P38646 | S65 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | HSPA9 GRP75 HSPA9B mt-HSP70 | DyASEAIKGAVVGIDLGtTNsCVAVMEGKQAKVLENAEGAR |
| P38646 | T62 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | HSPA9 GRP75 HSPA9B mt-HSP70 | SRRDyASEAIKGAVVGIDLGtTNsCVAVMEGKQAKVLENAE |
| P54132 | S1290 | EPSD|PSP | BLM RECQ2 RECQL3 | KLEKYGAEVIsVLQKYSEWTsPAEDssPGIsLsSSRGPGRs |
| P54132 | S1296 | EPSD|PSP | BLM RECQ2 RECQL3 | AEVIsVLQKYSEWTsPAEDssPGIsLsSSRGPGRsAAEELD |
| P54132 | S144 | EPSD|PSP | BLM RECQ2 RECQL3 | NtPtVKKSRDTALKKLEFsssPDsLstINDWDDMDDFDTSE |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q14247 | T328 | Sugiyama | CTTN EMS1 | GKyGVQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKts |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q53HL2 | S238 | GPS6|EPSD|PSP | CDCA8 PESCRG3 | GsPLADsKEIFLtVPVGGGEsLRLLAsDLQRHsIAQLDPEA |
| Q53HL2 | T169 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDCA8 PESCRG3 | KKRTQsIQGKGKGKRSsRANtVTPAVGRLEVSMVKPTPGLT |
| Q53HL2 | T230 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDCA8 PESCRG3 | RIyNIsGNGsPLADsKEIFLtVPVGGGEsLRLLAsDLQRHs |
| Q53HL2 | T88 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDCA8 PESCRG3 | MNWLDYFALGGNKQALEEAAtADLDItEINKLTAEAIQtPL |
| Q53HL2 | T94 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDCA8 PESCRG3 | FALGGNKQALEEAAtADLDItEINKLTAEAIQtPLKsAKTR |
| Q6IBW4 | S492 | PSP | NCAPH2 CAPH2 | RRNVELFIATSQKFVQETELsQRIRDWEDtVQPLLQEQEQH |
| Q96B36 | T233 | Sugiyama | AKT1S1 PRAS40 | PDLDRIAAsMRALVLREAEDtQVFGDLPRPRLNtsDFQKLK |
| Q96E14 | S112 | EPSD|PSP | RMI2 C16orf75 | GRPCLVPGKYVMVMGVVQACsPEPCLQAVKMTDLSDNPIHE |
| Q96PE2 | T1007 | EPSD|PSP | ARHGEF17 KIAA0337 TEM4 | PIGFPTRAHPTLQAPsLEDVtKQYMLNLHSGEVPAPVPVDM |
| Q96PE2 | T751 | EPSD|PSP | ARHGEF17 KIAA0337 TEM4 | YRsLsDPIPQRHRAATSEEPtGFSVDSNLLGsLsPKTGLPA |
| Q96PE2 | T944 | EPSD|PSP | ARHGEF17 KIAA0337 TEM4 | KRPARSSHQELRRDEGSQDQtGsLSRARPSSRHVRHAsVPA |
| Q9BQ16 | T118 | Sugiyama | SPOCK3 TICN3 UNQ409/PRO771 | HKVCIAQDSQTAVCISHRRLtHRMKEAGVDHRQWRGPILST |
| Q9H444 | T103 | Sugiyama | CHMP4B C20orf178 SHAX1 | DGtLstIEFQREALENANtNtEVLKNMGYAAKAMKAAHDNM |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y5T5 | S415 | SIGNOR|EPSD|PSP | USP16 MSTP039 | GKKSVNDKNLKKTVEDEDQDsEEEKDNDsYIKERSDIPSGT |
| Q9Y5T5 | S552 | EPSD|PSP | USP16 MSTP039 | TEEVDMKNINMDNDLEVLtssPtRNLNGAYLTEGSNGEVDI |
| Q9Y5T5 | T554 | SIGNOR|EPSD|PSP | USP16 MSTP039 | EVDMKNINMDNDLEVLtssPtRNLNGAYLTEGSNGEVDISN |
| Q9Y6D9 | S22 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | EDLGENtMVLSTLRsLNNFIsQRVEGGsGLDISTSAPGSLQ |
| Q9Y6D9 | S598 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | MERGGTVPADLEAAAASLPSsKEVAELKKQVEsAELKNQRL |
| Q9Y6D9 | S610 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | AAAASLPSsKEVAELKKQVEsAELKNQRLKEVFQtKIQEFR |
| Q9Y6D9 | S62 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | QMQYQQSMQLEERAEQIRSKsHLIQVEREKMQMELsHKRAR |
| Q9Y6D9 | T323 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | LELENERLLAKLQSWERLDQtMGLSIRTPEDLSRFVVELQQ |
| Q9Y6D9 | T624 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | LKKQVEsAELKNQRLKEVFQtKIQEFRKACyTLTGYQIDIT |
| Q9Y6D9 | T716 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | RQDsIPAFLSSLtLELFSRQtVA__________________ |
| Q9Y6D9 | T8 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | _____________MEDLGENtMVLSTLRsLNNFIsQRVEGG |
| Q9Y6R1 | S12 | PSP | SLC4A4 NBC NBC1 NBCE1 | _________MEDEAVLDRGAsFLKHVCDEEEVEGHHTIYIG |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.027584e-07 | 6.988 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.464327e-07 | 6.834 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.805273e-06 | 5.420 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.804332e-06 | 5.236 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.520482e-06 | 5.021 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.372160e-05 | 4.863 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.536895e-05 | 4.596 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.212533e-05 | 4.142 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.891845e-04 | 3.723 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.084942e-04 | 3.681 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.473008e-04 | 3.607 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.487595e-04 | 3.457 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.504640e-04 | 3.455 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.504640e-04 | 3.455 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.763169e-04 | 3.239 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.763169e-04 | 3.239 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.763169e-04 | 3.239 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.763169e-04 | 3.239 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.763169e-04 | 3.239 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.763169e-04 | 3.239 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.763169e-04 | 3.239 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.763169e-04 | 3.239 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.763169e-04 | 3.239 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.763169e-04 | 3.239 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.763169e-04 | 3.239 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.852068e-04 | 3.314 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.717351e-04 | 3.243 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.260210e-04 | 3.279 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.038130e-04 | 3.219 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.545198e-04 | 3.184 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.068506e-04 | 3.151 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 7.516258e-04 | 3.124 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.981773e-04 | 3.047 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.723317e-04 | 3.059 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.037025e-03 | 2.984 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.031594e-03 | 2.986 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.040826e-03 | 2.983 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.297868e-03 | 2.887 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.286375e-03 | 2.891 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.692330e-03 | 2.772 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.644690e-03 | 2.784 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.758733e-03 | 2.755 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.968495e-03 | 2.706 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.968495e-03 | 2.706 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.958105e-03 | 2.708 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.192568e-03 | 2.659 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.220164e-03 | 2.654 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.342162e-03 | 2.630 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.381365e-03 | 2.623 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.381365e-03 | 2.623 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.526210e-03 | 2.598 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.671878e-03 | 2.573 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.622011e-03 | 2.581 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.923868e-03 | 2.534 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.923868e-03 | 2.534 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.996576e-03 | 2.523 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.153989e-03 | 2.501 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.351370e-03 | 2.475 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.242123e-03 | 2.489 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.289515e-03 | 2.483 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.351370e-03 | 2.475 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.435000e-03 | 2.464 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.568272e-03 | 2.448 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.104830e-03 | 2.387 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.104830e-03 | 2.387 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.996122e-03 | 2.398 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.996122e-03 | 2.398 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.959691e-03 | 2.402 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.104830e-03 | 2.387 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.059841e-03 | 2.391 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.553160e-03 | 2.342 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.873227e-03 | 2.312 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.675365e-03 | 2.330 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.914060e-03 | 2.309 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.953254e-03 | 2.305 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.084977e-03 | 2.294 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.265479e-03 | 2.279 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.678094e-03 | 2.246 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.897074e-03 | 2.229 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.216994e-03 | 2.206 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.216994e-03 | 2.206 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.966247e-03 | 2.224 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.216994e-03 | 2.206 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.358198e-03 | 2.197 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.152442e-03 | 2.211 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.200579e-03 | 2.143 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.753089e-03 | 2.170 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.825083e-03 | 2.166 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.109118e-03 | 2.148 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.955106e-03 | 2.158 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.819991e-03 | 2.166 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.429711e-03 | 2.129 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.483507e-03 | 2.126 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.567472e-03 | 2.121 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.864255e-03 | 2.104 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.906329e-03 | 2.102 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.132494e-03 | 2.090 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.927087e-03 | 2.049 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.306613e-03 | 2.081 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.618326e-03 | 2.065 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.092588e-03 | 2.041 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.227021e-03 | 2.035 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.236689e-03 | 2.034 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.334626e-03 | 2.030 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.334626e-03 | 2.030 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.548832e-03 | 2.020 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.072717e-02 | 1.970 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.050859e-02 | 1.978 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.049466e-02 | 1.979 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.054953e-02 | 1.977 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.089732e-02 | 1.963 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.153582e-02 | 1.938 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.231714e-02 | 1.909 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.178676e-02 | 1.929 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.234595e-02 | 1.908 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.234595e-02 | 1.908 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.234595e-02 | 1.908 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.180566e-02 | 1.928 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.224763e-02 | 1.912 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.265593e-02 | 1.898 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.329483e-02 | 1.876 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.399112e-02 | 1.854 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.399112e-02 | 1.854 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.430824e-02 | 1.844 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.358185e-02 | 1.867 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.365959e-02 | 1.865 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.358811e-02 | 1.867 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.432149e-02 | 1.844 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.454780e-02 | 1.837 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.454780e-02 | 1.837 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.475546e-02 | 1.831 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.509724e-02 | 1.821 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.520329e-02 | 1.818 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.525335e-02 | 1.817 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.525335e-02 | 1.817 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.559019e-02 | 1.807 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.569333e-02 | 1.804 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.571136e-02 | 1.804 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.851401e-02 | 1.732 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.851401e-02 | 1.732 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.667921e-02 | 1.778 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.735863e-02 | 1.760 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.736427e-02 | 1.760 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.851401e-02 | 1.732 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.866028e-02 | 1.729 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.928314e-02 | 1.715 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.969322e-02 | 1.706 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.970019e-02 | 1.706 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.970338e-02 | 1.705 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.988858e-02 | 1.701 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.014720e-02 | 1.696 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.029883e-02 | 1.693 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.384728e-02 | 1.623 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.384728e-02 | 1.623 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.134684e-02 | 1.671 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.396832e-02 | 1.620 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.134684e-02 | 1.671 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.134684e-02 | 1.671 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.288912e-02 | 1.640 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.134684e-02 | 1.671 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.145903e-02 | 1.668 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.213084e-02 | 1.655 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.298649e-02 | 1.639 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.358011e-02 | 1.627 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.490639e-02 | 1.604 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.527056e-02 | 1.597 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.579725e-02 | 1.588 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.579725e-02 | 1.588 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.610471e-02 | 1.583 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.648376e-02 | 1.577 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.657482e-02 | 1.576 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.657482e-02 | 1.576 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.682613e-02 | 1.571 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.724328e-02 | 1.565 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.726262e-02 | 1.564 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.897631e-02 | 1.538 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.897631e-02 | 1.538 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.316483e-02 | 1.479 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.483458e-02 | 1.458 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.483458e-02 | 1.458 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.276341e-02 | 1.485 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.132269e-02 | 1.504 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.402267e-02 | 1.468 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.304688e-02 | 1.481 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.163818e-02 | 1.500 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.043459e-02 | 1.517 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.242225e-02 | 1.489 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 3.163818e-02 | 1.500 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.429193e-02 | 1.465 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.043459e-02 | 1.517 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.316483e-02 | 1.479 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.484795e-02 | 1.458 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.511780e-02 | 1.454 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.542289e-02 | 1.451 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.547570e-02 | 1.450 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.547570e-02 | 1.450 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.664768e-02 | 1.436 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.668663e-02 | 1.435 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.698466e-02 | 1.432 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.992695e-02 | 1.399 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.992695e-02 | 1.399 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.992695e-02 | 1.399 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.015015e-02 | 1.396 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 4.015015e-02 | 1.396 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.015015e-02 | 1.396 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.058696e-02 | 1.392 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.686390e-02 | 1.329 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.686390e-02 | 1.329 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.622719e-02 | 1.335 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.622719e-02 | 1.335 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.622719e-02 | 1.335 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.301913e-02 | 1.366 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.856651e-02 | 1.314 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.121768e-02 | 1.385 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.841141e-02 | 1.315 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.181465e-02 | 1.379 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.925690e-02 | 1.308 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.552610e-02 | 1.342 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.825884e-02 | 1.316 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.474269e-02 | 1.349 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.595866e-02 | 1.338 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.284782e-02 | 1.368 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.833150e-02 | 1.316 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.593072e-02 | 1.338 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.686390e-02 | 1.329 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.927970e-02 | 1.307 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.958647e-02 | 1.305 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.962869e-02 | 1.304 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.970188e-02 | 1.304 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.970188e-02 | 1.304 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.970188e-02 | 1.304 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.572717e-02 | 1.121 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 7.572717e-02 | 1.121 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 7.572717e-02 | 1.121 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 7.572717e-02 | 1.121 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 7.572717e-02 | 1.121 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 7.572717e-02 | 1.121 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 7.572717e-02 | 1.121 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 7.572717e-02 | 1.121 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 7.572717e-02 | 1.121 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 7.572717e-02 | 1.121 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 7.572717e-02 | 1.121 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 7.572717e-02 | 1.121 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.982482e-02 | 1.223 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.982482e-02 | 1.223 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.982482e-02 | 1.223 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.982482e-02 | 1.223 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.058282e-02 | 1.151 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.058282e-02 | 1.151 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.058282e-02 | 1.151 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.058282e-02 | 1.151 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.191191e-02 | 1.087 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.191191e-02 | 1.087 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.031694e-02 | 1.153 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.729134e-02 | 1.112 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.729134e-02 | 1.112 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.729134e-02 | 1.112 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.729134e-02 | 1.112 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.729134e-02 | 1.112 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.308571e-02 | 1.275 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.050425e-02 | 1.218 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.149792e-02 | 1.288 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.149792e-02 | 1.288 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.428479e-02 | 1.192 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.428479e-02 | 1.192 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.499264e-02 | 1.125 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.091940e-02 | 1.293 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.729134e-02 | 1.112 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.848113e-02 | 1.164 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.877403e-02 | 1.104 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.455593e-02 | 1.073 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.172533e-02 | 1.088 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.672500e-02 | 1.246 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.364343e-02 | 1.196 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.364343e-02 | 1.196 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.493406e-02 | 1.188 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.050425e-02 | 1.218 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.527421e-02 | 1.123 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.527421e-02 | 1.123 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.011133e-02 | 1.221 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.493406e-02 | 1.188 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.364343e-02 | 1.196 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.493406e-02 | 1.188 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.787998e-02 | 1.109 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.729134e-02 | 1.112 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.848113e-02 | 1.164 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.108180e-02 | 1.292 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.762743e-02 | 1.170 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.058282e-02 | 1.151 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.191191e-02 | 1.087 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.446310e-02 | 1.191 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.031694e-02 | 1.153 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.031694e-02 | 1.153 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.454437e-02 | 1.073 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.729134e-02 | 1.112 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 8.191191e-02 | 1.087 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.729134e-02 | 1.112 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.207857e-02 | 1.207 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.527421e-02 | 1.123 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.974185e-02 | 1.157 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.767856e-02 | 1.239 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.092841e-02 | 1.215 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.729134e-02 | 1.112 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.031694e-02 | 1.153 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.152131e-02 | 1.089 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.152131e-02 | 1.089 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.982482e-02 | 1.223 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.058282e-02 | 1.151 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.058282e-02 | 1.151 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.559031e-02 | 1.122 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.364343e-02 | 1.196 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.031694e-02 | 1.153 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.982482e-02 | 1.223 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.982482e-02 | 1.223 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.191191e-02 | 1.087 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.020838e-02 | 1.220 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.333400e-02 | 1.273 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.672500e-02 | 1.246 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.142065e-02 | 1.089 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.236728e-02 | 1.140 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.550051e-02 | 1.256 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.608677e-02 | 1.065 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.611982e-02 | 1.065 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.974091e-02 | 1.047 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.074803e-02 | 1.042 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.114156e-01 | 0.953 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.114156e-01 | 0.953 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.114156e-01 | 0.953 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 1.114156e-01 | 0.953 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.114156e-01 | 0.953 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.114156e-01 | 0.953 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 1.114156e-01 | 0.953 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 1.114156e-01 | 0.953 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.114156e-01 | 0.953 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.114156e-01 | 0.953 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 9.375212e-02 | 1.028 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.375212e-02 | 1.028 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.060472e-01 | 0.975 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.187446e-01 | 0.925 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.187446e-01 | 0.925 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.187446e-01 | 0.925 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.317950e-01 | 0.880 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.317950e-01 | 0.880 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.317950e-01 | 0.880 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.317950e-01 | 0.880 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.317950e-01 | 0.880 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.317950e-01 | 0.880 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.317950e-01 | 0.880 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.317950e-01 | 0.880 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.209950e-02 | 1.036 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.079769e-01 | 0.967 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.162866e-01 | 0.934 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.162866e-01 | 0.934 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.248273e-01 | 0.904 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.782175e-02 | 1.010 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.166718e-01 | 0.933 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.569632e-02 | 1.019 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.369663e-01 | 0.863 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.219604e-01 | 0.914 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.036513e-01 | 0.984 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.036513e-01 | 0.984 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.127568e-01 | 0.948 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.288280e-01 | 0.890 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.166718e-01 | 0.933 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.991045e-02 | 1.000 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.079769e-01 | 0.967 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 1.275796e-01 | 0.894 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 1.187446e-01 | 0.925 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.965678e-02 | 1.001 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.166718e-01 | 0.933 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.275796e-01 | 0.894 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 9.375212e-02 | 1.028 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 1.300493e-01 | 0.886 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.102215e-01 | 0.958 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.205986e-02 | 1.036 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 9.375212e-02 | 1.028 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.110813e-01 | 0.954 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.187446e-01 | 0.925 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 1.079769e-01 | 0.967 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 9.782175e-02 | 1.010 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.317950e-01 | 0.880 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 1.248273e-01 | 0.904 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.054419e-01 | 0.977 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.300493e-01 | 0.886 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.317950e-01 | 0.880 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.248273e-01 | 0.904 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.595705e-02 | 1.018 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.162866e-01 | 0.934 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.114156e-01 | 0.953 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.187446e-01 | 0.925 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.166718e-01 | 0.933 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.991045e-02 | 1.000 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 1.335865e-01 | 0.874 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.209950e-02 | 1.036 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.114156e-01 | 0.953 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 9.209950e-02 | 1.036 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.128503e-01 | 0.947 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.128503e-01 | 0.947 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.485275e-02 | 1.023 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.369663e-01 | 0.863 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.248273e-01 | 0.904 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.060472e-01 | 0.975 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.162866e-01 | 0.934 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.202147e-01 | 0.920 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.205986e-02 | 1.036 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 9.375212e-02 | 1.028 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.317950e-01 | 0.880 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.079769e-01 | 0.967 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.079769e-01 | 0.967 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.890642e-02 | 1.005 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.188144e-02 | 1.037 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.188144e-02 | 1.037 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.050095e-01 | 0.979 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.127568e-01 | 0.948 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.300493e-01 | 0.886 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.237991e-01 | 0.907 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 9.375212e-02 | 1.028 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.102215e-01 | 0.958 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.166718e-01 | 0.933 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 9.375212e-02 | 1.028 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.188144e-02 | 1.037 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.162866e-01 | 0.934 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.162866e-01 | 0.934 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.187446e-01 | 0.925 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.370116e-01 | 0.863 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.378730e-01 | 0.861 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.382958e-01 | 0.859 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.391639e-01 | 0.856 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.425089e-01 | 0.846 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.425089e-01 | 0.846 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.425089e-01 | 0.846 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 1.425517e-01 | 0.846 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.425517e-01 | 0.846 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.425517e-01 | 0.846 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.425517e-01 | 0.846 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.425517e-01 | 0.846 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.425517e-01 | 0.846 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.457281e-01 | 0.836 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.787176e-01 | 0.748 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.787176e-01 | 0.748 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 1.787176e-01 | 0.748 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.104351e-01 | 0.677 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.104351e-01 | 0.677 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.104351e-01 | 0.677 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.104351e-01 | 0.677 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.104351e-01 | 0.677 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.409296e-01 | 0.618 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.409296e-01 | 0.618 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.409296e-01 | 0.618 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.702481e-01 | 0.568 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.702481e-01 | 0.568 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.702481e-01 | 0.568 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.702481e-01 | 0.568 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.702481e-01 | 0.568 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.702481e-01 | 0.568 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.451524e-01 | 0.838 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.451524e-01 | 0.838 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 1.451524e-01 | 0.838 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.587736e-01 | 0.799 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.726185e-01 | 0.763 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 1.726185e-01 | 0.763 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.726185e-01 | 0.763 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.726185e-01 | 0.763 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.866496e-01 | 0.729 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.008320e-01 | 0.697 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.151331e-01 | 0.667 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.151331e-01 | 0.667 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.151331e-01 | 0.667 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.517103e-01 | 0.819 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.517103e-01 | 0.819 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.295227e-01 | 0.639 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.705579e-01 | 0.768 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.705579e-01 | 0.768 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.439726e-01 | 0.613 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.802220e-01 | 0.744 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.802220e-01 | 0.744 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.802220e-01 | 0.744 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.584569e-01 | 0.588 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.999700e-01 | 0.699 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.999700e-01 | 0.699 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.729514e-01 | 0.564 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.729514e-01 | 0.564 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.100300e-01 | 0.678 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.100300e-01 | 0.678 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.100300e-01 | 0.678 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.660298e-01 | 0.780 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.660298e-01 | 0.780 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.874337e-01 | 0.541 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.201985e-01 | 0.657 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.451235e-01 | 0.838 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.304640e-01 | 0.637 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.476304e-01 | 0.831 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.722780e-01 | 0.565 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.296690e-01 | 0.639 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.828674e-01 | 0.548 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.828674e-01 | 0.548 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.464544e-01 | 0.608 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.046158e-01 | 0.689 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.107101e-01 | 0.676 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.356920e-01 | 0.628 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.729514e-01 | 0.564 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.729514e-01 | 0.564 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.705579e-01 | 0.768 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.866496e-01 | 0.729 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.304640e-01 | 0.637 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.828674e-01 | 0.548 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.512419e-01 | 0.600 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.104351e-01 | 0.677 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.451524e-01 | 0.838 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.439726e-01 | 0.613 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.584569e-01 | 0.588 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.213871e-01 | 0.655 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.729514e-01 | 0.564 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.100300e-01 | 0.678 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.101181e-01 | 0.678 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.104351e-01 | 0.677 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.409296e-01 | 0.618 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.409296e-01 | 0.618 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.726185e-01 | 0.763 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 1.866496e-01 | 0.729 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.008320e-01 | 0.697 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.999700e-01 | 0.699 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.585656e-01 | 0.800 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.201985e-01 | 0.657 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.201985e-01 | 0.657 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.980983e-01 | 0.703 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.485118e-01 | 0.605 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.726185e-01 | 0.763 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.702481e-01 | 0.568 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.151331e-01 | 0.667 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.999700e-01 | 0.699 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.101181e-01 | 0.678 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.420766e-01 | 0.616 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.295227e-01 | 0.639 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.151331e-01 | 0.667 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.151331e-01 | 0.667 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.549953e-01 | 0.593 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.782105e-01 | 0.749 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 1.457281e-01 | 0.836 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.104351e-01 | 0.677 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.409296e-01 | 0.618 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.702481e-01 | 0.568 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.702481e-01 | 0.568 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.151331e-01 | 0.667 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.295227e-01 | 0.639 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.894441e-01 | 0.538 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.610499e-01 | 0.793 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.705579e-01 | 0.768 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.304640e-01 | 0.637 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.451524e-01 | 0.838 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.304640e-01 | 0.637 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.935863e-01 | 0.713 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.828674e-01 | 0.548 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.828674e-01 | 0.548 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 1.866496e-01 | 0.729 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.980983e-01 | 0.703 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.712471e-01 | 0.567 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.587736e-01 | 0.799 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.726185e-01 | 0.763 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.999700e-01 | 0.699 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.100300e-01 | 0.678 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.201985e-01 | 0.657 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.035321e-01 | 0.691 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.726539e-01 | 0.564 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.764751e-01 | 0.753 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.010638e-01 | 0.697 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.726539e-01 | 0.564 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.622352e-01 | 0.581 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.258160e-01 | 0.646 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.430567e-01 | 0.614 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.787176e-01 | 0.748 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 2.702481e-01 | 0.568 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.295227e-01 | 0.639 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.729514e-01 | 0.564 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.585656e-01 | 0.800 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.583995e-01 | 0.800 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.634970e-01 | 0.579 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.807700e-01 | 0.552 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.807700e-01 | 0.552 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.807700e-01 | 0.552 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.964130e-01 | 0.707 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 1.705579e-01 | 0.768 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.802220e-01 | 0.744 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.585656e-01 | 0.800 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.722780e-01 | 0.565 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.610499e-01 | 0.793 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.201985e-01 | 0.657 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.380267e-01 | 0.623 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.807513e-01 | 0.552 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.450868e-01 | 0.838 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.813621e-01 | 0.551 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.060748e-01 | 0.686 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 2.894441e-01 | 0.538 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.999700e-01 | 0.699 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.469164e-01 | 0.833 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.899884e-01 | 0.721 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.661024e-01 | 0.575 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.980324e-01 | 0.703 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.104351e-01 | 0.677 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.409296e-01 | 0.618 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.409296e-01 | 0.618 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 2.702481e-01 | 0.568 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.866496e-01 | 0.729 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.295227e-01 | 0.639 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.828674e-01 | 0.548 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.330627e-01 | 0.633 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.451235e-01 | 0.838 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.408154e-01 | 0.618 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.745598e-01 | 0.561 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.676301e-01 | 0.572 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.454422e-01 | 0.837 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.451235e-01 | 0.838 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.451524e-01 | 0.838 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.893632e-01 | 0.539 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.517103e-01 | 0.819 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.610499e-01 | 0.793 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.201985e-01 | 0.657 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.807513e-01 | 0.552 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.782260e-01 | 0.556 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.044537e-01 | 0.689 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.999700e-01 | 0.699 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.874337e-01 | 0.541 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.617329e-01 | 0.582 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.722780e-01 | 0.565 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.183303e-01 | 0.661 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.542507e-01 | 0.812 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.666567e-01 | 0.574 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.585656e-01 | 0.800 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.495146e-01 | 0.825 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.559027e-01 | 0.592 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.451524e-01 | 0.838 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.850632e-01 | 0.733 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.380267e-01 | 0.623 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 1.587736e-01 | 0.799 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.874337e-01 | 0.541 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.702481e-01 | 0.568 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.729514e-01 | 0.564 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.100300e-01 | 0.678 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 2.295227e-01 | 0.639 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.809136e-01 | 0.743 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.676301e-01 | 0.572 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 2.464544e-01 | 0.608 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.008320e-01 | 0.697 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.880496e-01 | 0.541 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.750627e-01 | 0.561 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.485964e-01 | 0.828 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.661302e-01 | 0.575 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.295227e-01 | 0.639 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.897949e-01 | 0.538 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.908493e-01 | 0.536 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.908493e-01 | 0.536 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.934913e-01 | 0.532 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.934913e-01 | 0.532 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.934913e-01 | 0.532 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.934913e-01 | 0.532 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.947704e-01 | 0.531 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.969762e-01 | 0.527 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.981733e-01 | 0.526 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.981733e-01 | 0.526 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.984359e-01 | 0.525 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 2.984359e-01 | 0.525 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.984359e-01 | 0.525 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.984359e-01 | 0.525 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.984359e-01 | 0.525 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.984359e-01 | 0.525 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.984359e-01 | 0.525 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 2.984359e-01 | 0.525 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.984359e-01 | 0.525 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 2.984359e-01 | 0.525 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.015221e-01 | 0.521 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.018832e-01 | 0.520 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.018832e-01 | 0.520 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.018832e-01 | 0.520 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.018832e-01 | 0.520 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.033533e-01 | 0.518 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.041404e-01 | 0.517 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.041404e-01 | 0.517 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.092780e-01 | 0.510 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.148056e-01 | 0.502 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.148056e-01 | 0.502 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.157201e-01 | 0.501 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.157201e-01 | 0.501 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.157201e-01 | 0.501 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.162808e-01 | 0.500 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.162808e-01 | 0.500 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.162808e-01 | 0.500 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.162808e-01 | 0.500 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.165211e-01 | 0.500 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.245273e-01 | 0.489 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.254783e-01 | 0.487 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.255365e-01 | 0.487 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 3.255365e-01 | 0.487 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.255365e-01 | 0.487 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.255365e-01 | 0.487 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.255365e-01 | 0.487 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.255365e-01 | 0.487 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.255365e-01 | 0.487 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.255365e-01 | 0.487 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.255365e-01 | 0.487 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.255365e-01 | 0.487 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.255365e-01 | 0.487 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.255365e-01 | 0.487 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.255365e-01 | 0.487 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.263204e-01 | 0.486 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.287885e-01 | 0.483 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.287885e-01 | 0.483 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.287885e-01 | 0.483 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 3.305054e-01 | 0.481 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.306091e-01 | 0.481 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.306091e-01 | 0.481 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.306091e-01 | 0.481 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.321113e-01 | 0.479 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.321113e-01 | 0.479 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.361499e-01 | 0.473 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.361499e-01 | 0.473 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.448520e-01 | 0.462 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.448520e-01 | 0.462 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 3.448520e-01 | 0.462 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 3.448520e-01 | 0.462 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.448520e-01 | 0.462 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.448520e-01 | 0.462 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.468126e-01 | 0.460 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.494434e-01 | 0.457 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.510244e-01 | 0.455 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 3.511398e-01 | 0.455 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.515919e-01 | 0.454 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.515919e-01 | 0.454 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.515919e-01 | 0.454 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.515919e-01 | 0.454 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.515919e-01 | 0.454 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.515919e-01 | 0.454 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.515919e-01 | 0.454 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.515919e-01 | 0.454 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.515919e-01 | 0.454 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.515919e-01 | 0.454 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.515919e-01 | 0.454 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.515919e-01 | 0.454 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.515919e-01 | 0.454 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.531475e-01 | 0.452 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.554281e-01 | 0.449 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.574584e-01 | 0.447 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.574584e-01 | 0.447 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.589947e-01 | 0.445 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.589947e-01 | 0.445 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.589947e-01 | 0.445 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 3.589947e-01 | 0.445 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.626294e-01 | 0.441 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.632756e-01 | 0.440 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.632756e-01 | 0.440 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.641252e-01 | 0.439 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.671585e-01 | 0.435 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.680800e-01 | 0.434 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.687045e-01 | 0.433 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.687045e-01 | 0.433 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.730238e-01 | 0.428 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.730238e-01 | 0.428 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.730238e-01 | 0.428 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.730238e-01 | 0.428 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.766422e-01 | 0.424 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.766422e-01 | 0.424 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.766422e-01 | 0.424 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.766422e-01 | 0.424 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.766422e-01 | 0.424 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 3.766422e-01 | 0.424 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.766422e-01 | 0.424 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.766422e-01 | 0.424 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.766422e-01 | 0.424 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.766422e-01 | 0.424 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.766422e-01 | 0.424 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.766422e-01 | 0.424 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.766422e-01 | 0.424 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.766422e-01 | 0.424 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.775355e-01 | 0.423 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.775355e-01 | 0.423 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.782027e-01 | 0.422 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.786703e-01 | 0.422 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.786703e-01 | 0.422 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.863546e-01 | 0.413 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.869268e-01 | 0.412 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.869268e-01 | 0.412 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.892224e-01 | 0.410 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.892224e-01 | 0.410 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.897052e-01 | 0.409 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.910069e-01 | 0.408 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.951578e-01 | 0.403 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.951578e-01 | 0.403 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.951578e-01 | 0.403 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.975446e-01 | 0.401 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.006927e-01 | 0.397 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.006927e-01 | 0.397 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.006927e-01 | 0.397 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.006927e-01 | 0.397 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.007263e-01 | 0.397 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.007263e-01 | 0.397 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.007263e-01 | 0.397 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.007263e-01 | 0.397 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.007263e-01 | 0.397 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.007263e-01 | 0.397 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 4.007263e-01 | 0.397 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.007263e-01 | 0.397 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.007263e-01 | 0.397 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.007263e-01 | 0.397 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.039408e-01 | 0.394 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.051060e-01 | 0.392 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.102493e-01 | 0.387 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.117952e-01 | 0.385 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.127895e-01 | 0.384 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.143114e-01 | 0.383 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.204581e-01 | 0.376 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.205870e-01 | 0.376 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.205870e-01 | 0.376 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.205870e-01 | 0.376 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.205870e-01 | 0.376 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.214311e-01 | 0.375 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.238812e-01 | 0.373 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.238812e-01 | 0.373 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.238812e-01 | 0.373 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.238812e-01 | 0.373 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.238812e-01 | 0.373 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.238812e-01 | 0.373 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.238812e-01 | 0.373 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.238812e-01 | 0.373 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.277736e-01 | 0.369 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.277736e-01 | 0.369 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.277736e-01 | 0.369 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.277736e-01 | 0.369 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.281093e-01 | 0.368 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.292736e-01 | 0.367 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 4.301309e-01 | 0.366 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.357403e-01 | 0.361 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.387956e-01 | 0.358 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.387956e-01 | 0.358 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.387956e-01 | 0.358 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.393925e-01 | 0.357 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.395419e-01 | 0.357 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.410711e-01 | 0.355 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.410711e-01 | 0.355 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.411956e-01 | 0.355 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 4.461428e-01 | 0.351 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.461428e-01 | 0.351 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.461428e-01 | 0.351 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.461428e-01 | 0.351 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.461428e-01 | 0.351 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.461428e-01 | 0.351 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.461428e-01 | 0.351 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.474219e-01 | 0.349 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.513937e-01 | 0.345 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.513937e-01 | 0.345 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.541966e-01 | 0.343 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.541966e-01 | 0.343 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.541966e-01 | 0.343 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.541966e-01 | 0.343 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.541966e-01 | 0.343 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.541966e-01 | 0.343 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.560064e-01 | 0.341 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.584881e-01 | 0.339 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.615147e-01 | 0.336 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.671436e-01 | 0.331 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.671436e-01 | 0.331 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.671436e-01 | 0.331 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.671436e-01 | 0.331 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 4.671436e-01 | 0.331 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.675455e-01 | 0.330 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.675455e-01 | 0.330 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.675455e-01 | 0.330 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.675455e-01 | 0.330 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.675455e-01 | 0.330 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.675455e-01 | 0.330 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.675455e-01 | 0.330 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.675455e-01 | 0.330 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.675455e-01 | 0.330 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.675455e-01 | 0.330 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.675455e-01 | 0.330 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.675455e-01 | 0.330 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.675455e-01 | 0.330 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.721847e-01 | 0.326 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.729348e-01 | 0.325 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.735088e-01 | 0.325 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.799062e-01 | 0.319 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.799062e-01 | 0.319 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.799062e-01 | 0.319 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 4.799062e-01 | 0.319 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.799062e-01 | 0.319 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.799062e-01 | 0.319 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.799062e-01 | 0.319 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.799062e-01 | 0.319 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 4.881224e-01 | 0.311 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.881224e-01 | 0.311 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.881224e-01 | 0.311 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 4.881224e-01 | 0.311 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.881224e-01 | 0.311 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 4.881224e-01 | 0.311 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.881224e-01 | 0.311 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.919134e-01 | 0.308 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.960478e-01 | 0.304 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.011431e-01 | 0.300 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.011431e-01 | 0.300 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.011431e-01 | 0.300 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.011431e-01 | 0.300 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.011431e-01 | 0.300 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.011431e-01 | 0.300 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.048586e-01 | 0.297 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.048586e-01 | 0.297 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.048586e-01 | 0.297 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.048586e-01 | 0.297 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.048586e-01 | 0.297 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.079054e-01 | 0.294 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.079054e-01 | 0.294 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.079054e-01 | 0.294 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.079054e-01 | 0.294 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.079054e-01 | 0.294 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.079054e-01 | 0.294 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.079054e-01 | 0.294 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.079054e-01 | 0.294 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.079054e-01 | 0.294 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.108174e-01 | 0.292 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.164162e-01 | 0.287 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.170403e-01 | 0.286 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.170403e-01 | 0.286 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.203919e-01 | 0.284 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.228257e-01 | 0.282 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.267634e-01 | 0.278 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.267762e-01 | 0.278 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.269249e-01 | 0.278 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.269249e-01 | 0.278 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.269249e-01 | 0.278 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.269249e-01 | 0.278 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.269249e-01 | 0.278 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.269249e-01 | 0.278 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.269249e-01 | 0.278 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.269249e-01 | 0.278 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.269249e-01 | 0.278 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.269249e-01 | 0.278 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.269249e-01 | 0.278 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.269249e-01 | 0.278 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 5.269249e-01 | 0.278 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.269249e-01 | 0.278 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.269249e-01 | 0.278 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.290212e-01 | 0.277 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.298637e-01 | 0.276 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.298637e-01 | 0.276 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.314723e-01 | 0.275 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.391881e-01 | 0.268 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.404849e-01 | 0.267 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 5.407985e-01 | 0.267 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.407985e-01 | 0.267 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.407985e-01 | 0.267 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.452104e-01 | 0.263 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.452104e-01 | 0.263 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.452104e-01 | 0.263 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.452104e-01 | 0.263 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.452104e-01 | 0.263 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.452104e-01 | 0.263 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.452104e-01 | 0.263 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.468639e-01 | 0.262 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.523701e-01 | 0.258 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.523701e-01 | 0.258 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.545697e-01 | 0.256 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.547358e-01 | 0.256 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.602345e-01 | 0.252 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.627902e-01 | 0.250 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.627902e-01 | 0.250 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 5.627902e-01 | 0.250 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.627902e-01 | 0.250 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.627902e-01 | 0.250 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 5.627902e-01 | 0.250 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.627902e-01 | 0.250 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.627902e-01 | 0.250 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.627902e-01 | 0.250 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.627902e-01 | 0.250 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.627902e-01 | 0.250 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.627902e-01 | 0.250 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 5.627902e-01 | 0.250 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.627902e-01 | 0.250 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.629610e-01 | 0.250 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.637344e-01 | 0.249 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.637344e-01 | 0.249 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.637344e-01 | 0.249 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.702578e-01 | 0.244 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.702578e-01 | 0.244 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.702578e-01 | 0.244 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 5.748900e-01 | 0.240 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 5.748900e-01 | 0.240 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.748900e-01 | 0.240 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.748900e-01 | 0.240 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.756271e-01 | 0.240 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.796915e-01 | 0.237 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.796915e-01 | 0.237 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.796915e-01 | 0.237 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 5.796915e-01 | 0.237 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 5.796915e-01 | 0.237 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 5.850558e-01 | 0.233 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.858362e-01 | 0.232 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.858362e-01 | 0.232 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 5.858362e-01 | 0.232 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.866943e-01 | 0.232 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.929635e-01 | 0.227 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.930917e-01 | 0.227 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.959404e-01 | 0.225 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.959404e-01 | 0.225 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.959404e-01 | 0.225 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.959404e-01 | 0.225 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 5.959404e-01 | 0.225 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.959404e-01 | 0.225 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.959404e-01 | 0.225 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 5.959404e-01 | 0.225 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 5.959404e-01 | 0.225 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.965724e-01 | 0.224 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.008210e-01 | 0.221 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.070985e-01 | 0.217 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.070985e-01 | 0.217 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.070985e-01 | 0.217 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.077002e-01 | 0.216 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 6.101136e-01 | 0.215 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.115621e-01 | 0.214 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.115621e-01 | 0.214 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.115621e-01 | 0.214 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.115621e-01 | 0.214 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.115621e-01 | 0.214 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.115621e-01 | 0.214 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.115621e-01 | 0.214 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.115621e-01 | 0.214 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.115621e-01 | 0.214 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.115621e-01 | 0.214 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.115621e-01 | 0.214 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 6.115621e-01 | 0.214 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.174147e-01 | 0.209 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.174147e-01 | 0.209 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.174147e-01 | 0.209 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.174147e-01 | 0.209 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.184441e-01 | 0.209 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.257632e-01 | 0.204 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.265807e-01 | 0.203 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.265807e-01 | 0.203 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 6.265807e-01 | 0.203 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.265807e-01 | 0.203 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.265807e-01 | 0.203 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.265807e-01 | 0.203 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.265807e-01 | 0.203 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.275215e-01 | 0.202 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.275215e-01 | 0.202 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.291831e-01 | 0.201 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.361747e-01 | 0.196 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.374197e-01 | 0.196 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.374197e-01 | 0.196 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.388191e-01 | 0.195 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.388191e-01 | 0.195 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.410196e-01 | 0.193 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 6.410196e-01 | 0.193 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.410196e-01 | 0.193 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.414246e-01 | 0.193 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.427040e-01 | 0.192 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.427040e-01 | 0.192 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.430803e-01 | 0.192 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.453770e-01 | 0.190 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.466278e-01 | 0.189 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 6.514813e-01 | 0.186 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.541366e-01 | 0.184 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.549010e-01 | 0.184 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.549010e-01 | 0.184 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.549010e-01 | 0.184 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.549010e-01 | 0.184 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.549010e-01 | 0.184 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.565944e-01 | 0.183 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.582626e-01 | 0.182 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.596500e-01 | 0.181 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.651084e-01 | 0.177 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.658737e-01 | 0.177 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.682464e-01 | 0.175 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.682464e-01 | 0.175 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.682464e-01 | 0.175 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.682464e-01 | 0.175 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.682464e-01 | 0.175 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 6.682464e-01 | 0.175 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.682464e-01 | 0.175 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.682464e-01 | 0.175 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.749497e-01 | 0.171 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 6.749497e-01 | 0.171 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.758591e-01 | 0.170 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.810766e-01 | 0.167 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 6.810766e-01 | 0.167 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 6.810766e-01 | 0.167 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.810766e-01 | 0.167 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.810766e-01 | 0.167 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.838244e-01 | 0.165 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.838244e-01 | 0.165 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.838244e-01 | 0.165 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.838244e-01 | 0.165 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.863860e-01 | 0.163 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.866854e-01 | 0.163 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.878976e-01 | 0.162 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.924996e-01 | 0.160 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.924996e-01 | 0.160 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.934112e-01 | 0.159 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.934112e-01 | 0.159 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.934112e-01 | 0.159 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.934112e-01 | 0.159 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.972667e-01 | 0.157 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.984755e-01 | 0.156 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.012885e-01 | 0.154 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.052696e-01 | 0.152 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.052696e-01 | 0.152 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.052696e-01 | 0.152 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.052696e-01 | 0.152 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.052696e-01 | 0.152 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.052696e-01 | 0.152 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.052696e-01 | 0.152 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.052696e-01 | 0.152 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.052696e-01 | 0.152 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.052696e-01 | 0.152 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.088316e-01 | 0.149 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.088316e-01 | 0.149 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.092605e-01 | 0.149 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.166700e-01 | 0.145 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.166700e-01 | 0.145 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.166700e-01 | 0.145 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.166700e-01 | 0.145 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.166700e-01 | 0.145 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.166700e-01 | 0.145 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 7.166700e-01 | 0.145 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.166700e-01 | 0.145 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.173508e-01 | 0.144 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.173508e-01 | 0.144 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.173508e-01 | 0.144 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.173508e-01 | 0.144 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.190976e-01 | 0.143 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.194055e-01 | 0.143 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.232016e-01 | 0.141 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.238961e-01 | 0.140 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.244269e-01 | 0.140 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.246151e-01 | 0.140 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.276301e-01 | 0.138 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.276301e-01 | 0.138 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.276301e-01 | 0.138 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.276301e-01 | 0.138 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.276301e-01 | 0.138 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 7.276301e-01 | 0.138 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.297550e-01 | 0.137 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.329041e-01 | 0.135 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.350440e-01 | 0.134 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.356015e-01 | 0.133 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.381668e-01 | 0.132 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.381668e-01 | 0.132 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.381668e-01 | 0.132 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 7.381668e-01 | 0.132 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 7.381668e-01 | 0.132 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 7.404917e-01 | 0.130 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.418437e-01 | 0.130 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.470156e-01 | 0.127 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.478376e-01 | 0.126 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.478376e-01 | 0.126 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.482966e-01 | 0.126 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.550041e-01 | 0.122 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.580350e-01 | 0.120 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.580350e-01 | 0.120 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.580350e-01 | 0.120 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.580350e-01 | 0.120 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.580350e-01 | 0.120 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.580350e-01 | 0.120 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.580541e-01 | 0.120 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.619943e-01 | 0.118 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 7.666343e-01 | 0.115 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 7.666343e-01 | 0.115 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.673973e-01 | 0.115 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.673973e-01 | 0.115 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.673973e-01 | 0.115 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.673973e-01 | 0.115 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.673973e-01 | 0.115 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.708228e-01 | 0.113 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.708228e-01 | 0.113 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 7.708228e-01 | 0.113 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.754571e-01 | 0.110 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.763978e-01 | 0.110 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.763978e-01 | 0.110 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.827688e-01 | 0.106 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.850506e-01 | 0.105 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.850506e-01 | 0.105 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 7.850506e-01 | 0.105 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.850506e-01 | 0.105 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.850506e-01 | 0.105 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 7.850506e-01 | 0.105 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.850506e-01 | 0.105 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.882497e-01 | 0.103 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.918458e-01 | 0.101 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.924117e-01 | 0.101 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.924117e-01 | 0.101 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.924117e-01 | 0.101 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.933691e-01 | 0.101 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 7.933691e-01 | 0.101 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 7.944022e-01 | 0.100 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.003963e-01 | 0.097 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.008937e-01 | 0.096 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.008937e-01 | 0.096 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.008937e-01 | 0.096 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.013661e-01 | 0.096 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.013661e-01 | 0.096 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.013661e-01 | 0.096 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.013661e-01 | 0.096 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.013661e-01 | 0.096 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.039513e-01 | 0.095 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.052398e-01 | 0.094 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.062348e-01 | 0.094 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.090541e-01 | 0.092 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.090541e-01 | 0.092 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.119210e-01 | 0.090 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.119210e-01 | 0.090 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.122814e-01 | 0.090 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.164450e-01 | 0.088 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.164450e-01 | 0.088 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.164450e-01 | 0.088 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.164450e-01 | 0.088 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.174579e-01 | 0.088 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.174579e-01 | 0.088 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.174579e-01 | 0.088 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.174579e-01 | 0.088 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.174579e-01 | 0.088 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.213080e-01 | 0.085 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.215985e-01 | 0.085 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.228484e-01 | 0.085 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.235502e-01 | 0.084 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.235502e-01 | 0.084 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.235502e-01 | 0.084 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.235502e-01 | 0.084 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.235502e-01 | 0.084 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.246698e-01 | 0.084 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 8.280956e-01 | 0.082 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.303809e-01 | 0.081 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.303809e-01 | 0.081 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.303809e-01 | 0.081 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 8.303809e-01 | 0.081 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.303809e-01 | 0.081 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.303809e-01 | 0.081 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.303809e-01 | 0.081 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.339433e-01 | 0.079 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.369475e-01 | 0.077 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.369475e-01 | 0.077 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.381722e-01 | 0.077 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.432602e-01 | 0.074 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.432602e-01 | 0.074 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.432602e-01 | 0.074 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.432602e-01 | 0.074 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 8.493290e-01 | 0.071 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.493290e-01 | 0.071 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.493290e-01 | 0.071 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.493290e-01 | 0.071 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.511596e-01 | 0.070 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.522869e-01 | 0.069 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.551631e-01 | 0.068 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.551631e-01 | 0.068 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.607716e-01 | 0.065 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.607716e-01 | 0.065 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.661634e-01 | 0.062 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.713466e-01 | 0.060 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.713466e-01 | 0.060 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.713466e-01 | 0.060 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.763294e-01 | 0.057 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.763294e-01 | 0.057 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.763294e-01 | 0.057 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.807397e-01 | 0.055 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.811195e-01 | 0.055 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.811195e-01 | 0.055 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.811195e-01 | 0.055 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.811195e-01 | 0.055 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.811195e-01 | 0.055 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.811195e-01 | 0.055 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.857243e-01 | 0.053 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.857243e-01 | 0.053 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 8.857243e-01 | 0.053 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.901511e-01 | 0.051 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.901511e-01 | 0.051 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.901511e-01 | 0.051 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.901511e-01 | 0.051 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.970709e-01 | 0.047 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.984975e-01 | 0.046 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.984975e-01 | 0.046 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.984975e-01 | 0.046 | 0 | 0 |
| Translation | R-HSA-72766 | 9.006740e-01 | 0.045 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.024302e-01 | 0.045 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.067490e-01 | 0.043 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.098450e-01 | 0.041 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.098450e-01 | 0.041 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.098450e-01 | 0.041 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.098450e-01 | 0.041 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.102715e-01 | 0.041 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.121140e-01 | 0.040 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.133386e-01 | 0.039 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.133386e-01 | 0.039 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.157966e-01 | 0.038 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.166971e-01 | 0.038 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.199256e-01 | 0.036 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.230292e-01 | 0.035 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.230292e-01 | 0.035 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.230292e-01 | 0.035 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.282434e-01 | 0.032 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.288807e-01 | 0.032 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.288807e-01 | 0.032 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.288807e-01 | 0.032 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.288807e-01 | 0.032 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.307317e-01 | 0.031 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.342880e-01 | 0.030 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.342880e-01 | 0.030 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.342880e-01 | 0.030 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.342880e-01 | 0.030 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.352441e-01 | 0.029 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.373178e-01 | 0.028 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.392848e-01 | 0.027 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.392848e-01 | 0.027 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.395781e-01 | 0.027 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.416390e-01 | 0.026 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.427719e-01 | 0.026 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.427782e-01 | 0.026 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.427782e-01 | 0.026 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.427782e-01 | 0.026 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.463875e-01 | 0.024 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.481688e-01 | 0.023 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.481688e-01 | 0.023 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.481688e-01 | 0.023 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.487151e-01 | 0.023 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.501791e-01 | 0.022 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.539691e-01 | 0.020 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.557547e-01 | 0.020 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.557547e-01 | 0.020 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.557547e-01 | 0.020 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.574712e-01 | 0.019 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.574712e-01 | 0.019 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.575793e-01 | 0.019 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.591212e-01 | 0.018 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.600010e-01 | 0.018 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.604939e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.607072e-01 | 0.017 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.611626e-01 | 0.017 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.622318e-01 | 0.017 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.644603e-01 | 0.016 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.650634e-01 | 0.015 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.660700e-01 | 0.015 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.664603e-01 | 0.015 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.665034e-01 | 0.015 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.677621e-01 | 0.014 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.684486e-01 | 0.014 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.694234e-01 | 0.013 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.702161e-01 | 0.013 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.702161e-01 | 0.013 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.714021e-01 | 0.013 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.724836e-01 | 0.012 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.735518e-01 | 0.012 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.755658e-01 | 0.011 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.765145e-01 | 0.010 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.774265e-01 | 0.010 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.778519e-01 | 0.010 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.783032e-01 | 0.010 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.791458e-01 | 0.009 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.795806e-01 | 0.009 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.799558e-01 | 0.009 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.805514e-01 | 0.009 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.835581e-01 | 0.007 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.842381e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.870380e-01 | 0.006 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.871942e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.874798e-01 | 0.005 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.907133e-01 | 0.004 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.909450e-01 | 0.004 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.912812e-01 | 0.004 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.918743e-01 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.919462e-01 | 0.004 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.921279e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.922595e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.938995e-01 | 0.003 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.938995e-01 | 0.003 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.943650e-01 | 0.002 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.944914e-01 | 0.002 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.966373e-01 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.967413e-01 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.970051e-01 | 0.001 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.970151e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.970705e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.972782e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.972963e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.978778e-01 | 0.001 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.982891e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.985153e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.986132e-01 | 0.001 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.990198e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.992926e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.993938e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.994392e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.995919e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.996787e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.998798e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999308e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999471e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999832e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999969e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999999e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.485301e-14 | 13.348 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.215694e-13 | 12.915 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.060552e-12 | 11.514 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.872947e-12 | 11.163 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.829293e-12 | 11.106 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.678491e-11 | 10.246 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.147474e-10 | 9.211 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.674544e-10 | 9.062 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.932477e-09 | 8.533 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.926973e-09 | 8.406 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.394223e-09 | 8.131 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.045729e-07 | 6.981 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.422058e-07 | 6.847 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.748232e-07 | 6.757 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.230942e-07 | 6.652 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.640561e-07 | 6.439 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.874613e-07 | 6.412 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.895378e-07 | 6.409 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.729772e-07 | 6.325 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.786560e-07 | 6.238 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.292346e-07 | 6.201 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.292346e-07 | 6.201 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.011049e-06 | 5.995 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.487611e-06 | 5.828 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.521271e-06 | 5.818 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.237313e-06 | 5.650 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.226651e-06 | 5.491 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.763067e-06 | 5.424 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.033834e-06 | 5.394 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.804616e-06 | 5.236 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.089776e-06 | 5.215 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.275810e-06 | 5.202 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.579617e-06 | 5.120 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.049041e-05 | 4.979 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.197996e-05 | 4.922 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.271171e-05 | 4.896 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.513230e-05 | 4.820 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.479193e-05 | 4.830 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.163509e-05 | 4.665 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.523954e-05 | 4.598 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.568546e-05 | 4.590 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.690933e-05 | 4.570 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.897470e-05 | 4.538 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.897470e-05 | 4.538 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.897470e-05 | 4.538 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.897470e-05 | 4.538 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.984941e-05 | 4.525 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.220676e-05 | 4.492 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.263170e-05 | 4.486 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.314690e-05 | 4.480 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.899906e-05 | 4.409 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.899906e-05 | 4.409 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.992927e-05 | 4.399 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.109166e-05 | 4.386 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.496249e-05 | 4.347 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.912037e-05 | 4.309 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.060772e-05 | 4.296 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.360623e-05 | 4.271 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.360623e-05 | 4.271 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.634960e-05 | 4.249 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.795525e-05 | 4.237 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.194030e-05 | 4.208 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.425348e-05 | 4.192 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.425348e-05 | 4.192 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.175042e-05 | 4.144 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.384672e-05 | 4.077 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.536110e-05 | 4.069 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.117623e-05 | 4.040 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.645608e-05 | 4.016 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.027860e-04 | 3.988 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.121780e-04 | 3.950 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.097156e-04 | 3.960 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.097156e-04 | 3.960 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.143777e-04 | 3.942 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.188910e-04 | 3.925 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.195711e-04 | 3.922 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.311191e-04 | 3.882 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.313470e-04 | 3.882 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.455331e-04 | 3.837 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.455331e-04 | 3.837 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.455331e-04 | 3.837 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.564717e-04 | 3.806 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.588141e-04 | 3.799 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.626255e-04 | 3.789 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.828021e-04 | 3.738 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.772650e-04 | 3.751 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.750460e-04 | 3.757 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.750460e-04 | 3.757 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.855273e-04 | 3.732 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.001888e-04 | 3.699 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.138940e-04 | 3.670 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.208479e-04 | 3.656 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.392427e-04 | 3.621 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.432339e-04 | 3.614 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.440401e-04 | 3.613 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.569855e-04 | 3.590 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.569855e-04 | 3.590 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.573719e-04 | 3.589 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.791715e-04 | 3.554 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.815774e-04 | 3.550 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.039833e-04 | 3.517 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.366525e-04 | 3.473 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.435505e-04 | 3.464 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.648782e-04 | 3.438 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.659723e-04 | 3.437 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.773348e-04 | 3.423 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.810451e-04 | 3.419 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.324060e-04 | 3.364 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.209457e-04 | 3.376 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.314242e-04 | 3.365 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.567186e-04 | 3.340 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.567186e-04 | 3.340 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.685316e-04 | 3.329 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.851825e-04 | 3.314 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.967938e-04 | 3.304 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.076421e-04 | 3.294 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.163969e-04 | 3.287 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.440393e-04 | 3.264 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.043409e-04 | 3.219 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.197263e-04 | 3.208 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.933107e-04 | 3.159 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.745956e-04 | 3.171 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.326340e-04 | 3.199 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.791837e-04 | 3.168 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.800132e-04 | 3.167 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.810517e-04 | 3.107 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 8.143758e-04 | 3.089 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 8.143758e-04 | 3.089 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.159482e-04 | 3.088 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.305336e-04 | 3.081 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.305336e-04 | 3.081 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.591950e-04 | 3.066 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.035341e-04 | 3.044 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.309955e-04 | 3.031 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.908838e-04 | 3.004 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.005726e-03 | 2.998 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.072489e-03 | 2.970 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.107581e-03 | 2.956 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.094755e-03 | 2.961 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.029778e-03 | 2.987 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.125248e-03 | 2.949 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.125248e-03 | 2.949 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.194641e-03 | 2.923 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.194641e-03 | 2.923 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.288904e-03 | 2.890 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.288904e-03 | 2.890 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.332832e-03 | 2.875 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.338350e-03 | 2.873 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.348126e-03 | 2.870 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.348126e-03 | 2.870 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.348126e-03 | 2.870 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.375205e-03 | 2.862 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.375205e-03 | 2.862 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.491044e-03 | 2.827 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.491044e-03 | 2.827 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.553008e-03 | 2.809 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.553008e-03 | 2.809 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.595094e-03 | 2.797 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.595094e-03 | 2.797 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.596535e-03 | 2.797 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.604291e-03 | 2.795 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.604291e-03 | 2.795 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.604291e-03 | 2.795 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.697302e-03 | 2.770 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.697302e-03 | 2.770 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.703267e-03 | 2.769 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.703267e-03 | 2.769 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.953637e-03 | 2.709 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.953637e-03 | 2.709 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.953637e-03 | 2.709 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.953637e-03 | 2.709 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.907283e-03 | 2.720 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.953637e-03 | 2.709 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.756319e-03 | 2.755 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.953637e-03 | 2.709 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.822361e-03 | 2.739 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.844388e-03 | 2.734 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.737653e-03 | 2.760 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.892083e-03 | 2.723 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.003898e-03 | 2.698 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.063508e-03 | 2.685 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.063508e-03 | 2.685 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.094478e-03 | 2.679 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.203899e-03 | 2.657 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.279427e-03 | 2.642 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.370001e-03 | 2.625 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.370001e-03 | 2.625 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.351676e-03 | 2.629 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.351676e-03 | 2.629 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.329426e-03 | 2.633 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.605020e-03 | 2.584 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.583832e-03 | 2.588 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.605020e-03 | 2.584 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.346277e-03 | 2.630 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.672618e-03 | 2.573 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.329426e-03 | 2.633 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.583832e-03 | 2.588 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.640227e-03 | 2.578 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.640227e-03 | 2.578 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.359824e-03 | 2.627 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.583832e-03 | 2.588 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.583832e-03 | 2.588 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.804845e-03 | 2.552 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.804845e-03 | 2.552 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.849808e-03 | 2.545 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.874841e-03 | 2.541 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.929295e-03 | 2.533 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.942660e-03 | 2.531 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.942660e-03 | 2.531 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.942660e-03 | 2.531 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.942660e-03 | 2.531 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.942660e-03 | 2.531 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.185068e-03 | 2.497 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.293652e-03 | 2.482 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.237942e-03 | 2.490 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.237942e-03 | 2.490 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.517420e-03 | 2.454 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.398801e-03 | 2.469 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.112436e-03 | 2.507 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.580392e-03 | 2.446 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.112436e-03 | 2.507 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.159454e-03 | 2.500 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.583011e-03 | 2.446 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.398801e-03 | 2.469 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.112436e-03 | 2.507 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.398801e-03 | 2.469 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.112436e-03 | 2.507 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.185068e-03 | 2.497 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.112436e-03 | 2.507 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.583011e-03 | 2.446 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.992771e-03 | 2.524 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.580392e-03 | 2.446 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.112436e-03 | 2.507 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.689594e-03 | 2.433 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.728955e-03 | 2.428 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.860816e-03 | 2.413 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.950614e-03 | 2.403 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.950614e-03 | 2.403 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.964819e-03 | 2.402 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.043479e-03 | 2.393 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.179795e-03 | 2.379 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.226994e-03 | 2.374 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.226994e-03 | 2.374 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.807776e-03 | 2.318 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.807776e-03 | 2.318 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.807776e-03 | 2.318 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 4.807776e-03 | 2.318 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.807776e-03 | 2.318 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.807776e-03 | 2.318 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.519545e-03 | 2.258 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.234860e-03 | 2.281 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.657042e-03 | 2.332 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.835721e-03 | 2.316 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.508170e-03 | 2.259 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.835721e-03 | 2.316 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 4.729848e-03 | 2.325 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.712928e-03 | 2.243 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.825075e-03 | 2.316 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.729848e-03 | 2.325 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.729848e-03 | 2.325 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.729848e-03 | 2.325 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.657042e-03 | 2.332 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.729425e-03 | 2.242 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.727755e-03 | 2.325 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.727755e-03 | 2.325 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.508170e-03 | 2.259 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.038640e-03 | 2.298 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.729425e-03 | 2.242 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.835721e-03 | 2.316 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.508170e-03 | 2.259 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.657042e-03 | 2.332 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.712928e-03 | 2.243 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.215200e-03 | 2.283 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.686672e-03 | 2.245 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.836098e-03 | 2.234 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.012893e-03 | 2.221 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.021692e-03 | 2.220 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.144204e-03 | 2.212 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.144204e-03 | 2.212 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.158838e-03 | 2.211 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.248300e-03 | 2.204 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.248300e-03 | 2.204 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.248300e-03 | 2.204 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.248300e-03 | 2.204 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.372116e-03 | 2.196 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.372116e-03 | 2.196 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.372116e-03 | 2.196 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.372116e-03 | 2.196 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.404119e-03 | 2.194 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.404119e-03 | 2.194 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.404119e-03 | 2.194 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.060087e-03 | 2.151 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.087394e-03 | 2.150 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 7.092434e-03 | 2.149 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.385826e-03 | 2.132 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.427645e-03 | 2.129 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.430795e-03 | 2.129 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.430795e-03 | 2.129 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.629105e-03 | 2.118 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.629105e-03 | 2.118 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.629105e-03 | 2.118 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 7.947512e-03 | 2.100 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.947512e-03 | 2.100 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.947512e-03 | 2.100 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 7.947512e-03 | 2.100 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.947512e-03 | 2.100 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.123783e-03 | 2.090 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.158761e-03 | 2.088 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.158761e-03 | 2.088 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.697727e-03 | 2.061 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.766162e-03 | 2.057 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.766162e-03 | 2.057 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.801287e-03 | 2.055 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.906328e-03 | 2.050 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.914551e-03 | 2.050 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.119414e-03 | 2.040 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.607092e-03 | 2.017 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.499216e-03 | 2.022 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.110479e-02 | 1.954 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.110324e-02 | 1.955 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.110479e-02 | 1.954 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.233267e-02 | 1.909 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.163609e-02 | 1.934 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.160595e-02 | 1.935 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.513623e-03 | 2.022 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.224041e-02 | 1.912 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.046230e-02 | 1.980 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.160595e-02 | 1.935 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.597431e-03 | 2.018 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 9.495620e-03 | 2.022 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.022296e-02 | 1.990 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.607092e-03 | 2.017 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.152893e-02 | 1.938 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.965155e-03 | 2.002 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.607092e-03 | 2.017 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.209458e-02 | 1.917 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 9.495620e-03 | 2.022 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 9.495620e-03 | 2.022 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.122299e-02 | 1.950 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.110324e-02 | 1.955 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.233267e-02 | 1.909 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.724377e-03 | 2.012 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.098729e-02 | 1.959 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.163609e-02 | 1.934 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.495620e-03 | 2.022 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.495620e-03 | 2.022 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.152893e-02 | 1.938 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.188926e-02 | 1.925 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.242278e-02 | 1.906 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.242278e-02 | 1.906 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.242278e-02 | 1.906 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.271824e-02 | 1.896 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.271824e-02 | 1.896 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.292755e-02 | 1.888 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.301479e-02 | 1.886 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.316836e-02 | 1.880 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.365724e-02 | 1.865 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.365724e-02 | 1.865 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.365724e-02 | 1.865 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.365724e-02 | 1.865 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.369182e-02 | 1.864 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.369182e-02 | 1.864 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.383119e-02 | 1.859 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.388810e-02 | 1.857 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.390670e-02 | 1.857 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.398506e-02 | 1.854 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.406379e-02 | 1.852 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.406379e-02 | 1.852 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.406379e-02 | 1.852 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.406379e-02 | 1.852 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.491584e-02 | 1.826 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.491584e-02 | 1.826 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.508068e-02 | 1.822 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.511605e-02 | 1.821 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.517411e-02 | 1.819 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.567931e-02 | 1.805 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.567931e-02 | 1.805 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.586996e-02 | 1.799 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.601399e-02 | 1.796 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.603392e-02 | 1.795 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.660663e-02 | 1.780 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.660663e-02 | 1.780 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.665262e-02 | 1.779 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.679042e-02 | 1.775 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.679042e-02 | 1.775 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.679042e-02 | 1.775 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.679042e-02 | 1.775 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.679042e-02 | 1.775 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.707451e-02 | 1.768 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.725916e-02 | 1.763 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.795670e-02 | 1.746 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.795670e-02 | 1.746 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.799152e-02 | 1.745 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.799152e-02 | 1.745 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.799152e-02 | 1.745 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.799152e-02 | 1.745 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.799152e-02 | 1.745 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.799152e-02 | 1.745 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.799152e-02 | 1.745 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.799152e-02 | 1.745 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.799152e-02 | 1.745 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.799152e-02 | 1.745 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.799152e-02 | 1.745 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.799152e-02 | 1.745 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.823861e-02 | 1.739 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.836827e-02 | 1.736 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.913415e-02 | 1.718 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.948326e-02 | 1.710 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.948326e-02 | 1.710 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.948326e-02 | 1.710 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.948326e-02 | 1.710 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.982602e-02 | 1.703 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.982602e-02 | 1.703 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.984299e-02 | 1.702 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.998005e-02 | 1.699 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.998005e-02 | 1.699 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.998005e-02 | 1.699 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.097646e-02 | 1.678 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.097646e-02 | 1.678 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.108729e-02 | 1.676 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.160219e-02 | 1.666 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.164910e-02 | 1.665 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.173079e-02 | 1.663 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.183424e-02 | 1.661 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.719653e-02 | 1.565 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.719653e-02 | 1.565 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.719653e-02 | 1.565 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.719653e-02 | 1.565 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.394434e-02 | 1.621 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.934691e-02 | 1.532 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.317904e-02 | 1.635 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.317904e-02 | 1.635 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.786198e-02 | 1.555 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.458610e-02 | 1.609 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.697112e-02 | 1.569 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.697112e-02 | 1.569 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.965212e-02 | 1.528 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.273061e-02 | 1.643 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.237489e-02 | 1.650 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.984981e-02 | 1.525 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.486869e-02 | 1.604 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.286900e-02 | 1.641 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.285934e-02 | 1.641 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.685629e-02 | 1.571 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.647957e-02 | 1.577 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.387145e-02 | 1.622 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.835766e-02 | 1.547 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.387145e-02 | 1.622 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.471001e-02 | 1.607 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.107448e-02 | 1.508 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.086302e-02 | 1.511 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.209022e-02 | 1.656 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.914513e-02 | 1.535 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.992264e-02 | 1.524 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.647957e-02 | 1.577 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.921253e-02 | 1.534 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.107448e-02 | 1.508 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.387145e-02 | 1.622 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.853623e-02 | 1.545 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.786198e-02 | 1.555 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.810417e-02 | 1.551 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.290178e-02 | 1.483 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.086302e-02 | 1.511 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.290178e-02 | 1.483 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.217139e-02 | 1.493 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.161924e-02 | 1.500 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.450998e-02 | 1.462 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.450998e-02 | 1.462 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.450998e-02 | 1.462 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.452633e-02 | 1.462 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.477644e-02 | 1.459 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.506486e-02 | 1.455 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.506486e-02 | 1.455 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 3.520294e-02 | 1.453 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.520294e-02 | 1.453 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.520294e-02 | 1.453 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.549347e-02 | 1.450 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.561304e-02 | 1.448 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.561304e-02 | 1.448 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.561304e-02 | 1.448 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.651207e-02 | 1.438 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.760046e-02 | 1.425 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 3.789353e-02 | 1.421 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.789353e-02 | 1.421 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.937600e-02 | 1.405 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.945275e-02 | 1.404 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.987825e-02 | 1.399 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.999169e-02 | 1.398 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.021275e-02 | 1.396 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.190726e-02 | 1.378 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.206192e-02 | 1.376 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.357124e-02 | 1.361 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.425907e-02 | 1.354 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.425907e-02 | 1.354 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.425907e-02 | 1.354 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.471669e-02 | 1.350 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.475102e-02 | 1.349 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.488974e-02 | 1.348 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.488974e-02 | 1.348 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 4.488974e-02 | 1.348 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.488974e-02 | 1.348 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 4.488974e-02 | 1.348 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.510937e-02 | 1.346 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.573742e-02 | 1.340 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.573742e-02 | 1.340 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.618272e-02 | 1.336 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.618272e-02 | 1.336 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.670593e-02 | 1.331 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.719445e-02 | 1.326 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.821212e-02 | 1.317 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.904403e-02 | 1.309 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.904403e-02 | 1.309 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 4.947181e-02 | 1.306 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 4.947181e-02 | 1.306 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 4.947181e-02 | 1.306 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.991271e-02 | 1.302 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.991271e-02 | 1.302 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.991271e-02 | 1.302 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.991271e-02 | 1.302 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.991271e-02 | 1.302 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.991271e-02 | 1.302 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.023683e-02 | 1.299 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.023683e-02 | 1.299 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.023683e-02 | 1.299 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.023683e-02 | 1.299 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 5.023683e-02 | 1.299 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.023683e-02 | 1.299 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.023683e-02 | 1.299 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.023683e-02 | 1.299 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.023683e-02 | 1.299 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.046168e-02 | 1.297 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.053530e-02 | 1.296 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.053530e-02 | 1.296 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.053530e-02 | 1.296 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.117908e-02 | 1.291 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.117908e-02 | 1.291 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.117908e-02 | 1.291 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.512027e-02 | 1.259 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.513471e-02 | 1.259 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.554879e-02 | 1.255 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.554879e-02 | 1.255 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.554879e-02 | 1.255 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.585869e-02 | 1.253 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.591766e-02 | 1.252 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.673228e-02 | 1.246 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.673228e-02 | 1.246 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.732819e-02 | 1.242 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.993766e-02 | 1.222 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.993766e-02 | 1.222 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.993766e-02 | 1.222 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.250412e-02 | 1.204 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.309742e-02 | 1.200 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.309742e-02 | 1.200 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.309742e-02 | 1.200 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.309742e-02 | 1.200 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.309742e-02 | 1.200 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.312248e-02 | 1.200 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.322012e-02 | 1.199 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.395541e-02 | 1.194 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.420828e-02 | 1.192 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.493406e-02 | 1.188 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.716113e-02 | 1.173 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.716434e-02 | 1.173 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.775951e-02 | 1.169 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.826700e-02 | 1.166 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.842392e-02 | 1.165 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.026688e-02 | 1.153 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.229418e-02 | 1.141 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.302093e-02 | 1.137 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.302093e-02 | 1.137 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.302093e-02 | 1.137 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.302588e-02 | 1.137 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.368855e-02 | 1.133 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.368855e-02 | 1.133 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.368855e-02 | 1.133 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.489141e-02 | 1.126 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.492598e-02 | 1.125 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.492598e-02 | 1.125 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.492598e-02 | 1.125 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 9.649901e-02 | 1.015 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 9.649901e-02 | 1.015 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 9.649901e-02 | 1.015 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 9.649901e-02 | 1.015 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 9.649901e-02 | 1.015 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.412023e-01 | 0.850 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.412023e-01 | 0.850 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.412023e-01 | 0.850 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.412023e-01 | 0.850 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.412023e-01 | 0.850 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.412023e-01 | 0.850 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.412023e-01 | 0.850 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 9.239709e-02 | 1.034 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 9.239709e-02 | 1.034 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.239709e-02 | 1.034 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.082566e-01 | 0.966 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.082566e-01 | 0.966 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.082566e-01 | 0.966 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.247693e-01 | 0.904 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.418320e-01 | 0.848 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.418320e-01 | 0.848 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.418320e-01 | 0.848 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.291408e-02 | 1.081 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.260688e-02 | 1.033 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.260688e-02 | 1.033 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.132944e-01 | 0.946 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.132944e-01 | 0.946 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.918121e-02 | 1.050 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.355440e-01 | 0.868 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.676225e-02 | 1.014 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.339784e-02 | 1.030 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.427405e-01 | 0.845 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.587801e-02 | 1.120 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.354301e-01 | 0.868 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.488367e-02 | 1.023 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.405241e-01 | 0.852 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.257192e-01 | 0.901 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.127874e-01 | 0.948 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.388323e-01 | 0.858 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.110105e-01 | 0.955 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.418320e-01 | 0.848 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.365238e-02 | 1.028 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.246548e-01 | 0.904 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.247693e-01 | 0.904 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.488426e-01 | 0.827 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.730322e-02 | 1.112 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.027422e-01 | 0.988 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.260688e-02 | 1.033 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 1.027422e-01 | 0.988 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.127874e-01 | 0.948 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.298973e-01 | 0.886 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.031960e-01 | 0.986 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.132944e-01 | 0.946 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.189978e-02 | 1.087 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.000503e-01 | 1.000 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.351396e-01 | 0.869 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.730322e-02 | 1.112 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.000503e-01 | 1.000 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.212613e-01 | 0.916 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.621677e-02 | 1.064 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.252785e-01 | 0.902 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 9.649901e-02 | 1.015 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 9.649901e-02 | 1.015 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.412023e-01 | 0.850 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.412023e-01 | 0.850 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.412023e-01 | 0.850 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 1.412023e-01 | 0.850 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.247693e-01 | 0.904 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.388323e-01 | 0.858 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.375365e-01 | 0.862 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.362555e-01 | 0.866 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 1.420630e-01 | 0.848 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.097820e-01 | 0.959 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.087911e-02 | 1.042 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.427405e-01 | 0.845 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.155895e-02 | 1.038 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.209386e-01 | 0.917 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.247693e-01 | 0.904 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.000503e-01 | 1.000 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.195274e-01 | 0.923 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.505221e-01 | 0.822 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.247693e-01 | 0.904 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.247693e-01 | 0.904 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.354301e-01 | 0.868 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.453668e-02 | 1.024 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.104383e-01 | 0.957 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.753241e-02 | 1.011 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.257192e-01 | 0.901 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.151171e-02 | 1.089 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.378683e-01 | 0.861 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.082566e-01 | 0.966 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.403946e-01 | 0.853 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.388323e-01 | 0.858 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.045914e-01 | 0.981 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.104383e-01 | 0.957 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.418320e-01 | 0.848 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.189978e-02 | 1.087 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.391617e-01 | 0.856 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.127874e-01 | 0.948 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.351261e-01 | 0.869 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.354301e-01 | 0.868 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 9.239709e-02 | 1.034 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.082566e-01 | 0.966 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.247693e-01 | 0.904 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.918121e-02 | 1.050 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.898946e-02 | 1.004 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.354301e-01 | 0.868 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.354301e-01 | 0.868 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.354301e-01 | 0.868 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.354301e-01 | 0.868 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.727774e-02 | 1.112 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.260688e-02 | 1.033 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.593972e-02 | 1.018 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.355440e-01 | 0.868 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.073993e-02 | 1.093 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 1.046341e-01 | 0.980 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.205040e-01 | 0.919 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.256418e-01 | 0.901 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.189978e-02 | 1.087 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.000503e-01 | 1.000 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.351396e-01 | 0.869 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.289478e-01 | 0.890 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.789402e-02 | 1.009 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.205040e-01 | 0.919 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.104383e-01 | 0.957 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.046341e-01 | 0.980 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.729218e-02 | 1.059 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.046341e-01 | 0.980 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.195846e-01 | 0.922 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.505746e-01 | 0.822 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.513069e-01 | 0.820 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.513069e-01 | 0.820 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.516364e-01 | 0.819 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.522247e-01 | 0.818 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.526797e-01 | 0.816 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.529704e-01 | 0.815 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.559040e-01 | 0.807 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.574054e-01 | 0.803 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.574054e-01 | 0.803 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.584777e-01 | 0.800 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.584777e-01 | 0.800 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 1.591424e-01 | 0.798 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.591424e-01 | 0.798 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.593500e-01 | 0.798 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.593500e-01 | 0.798 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.593500e-01 | 0.798 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.636750e-01 | 0.786 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.639275e-01 | 0.785 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.666009e-01 | 0.778 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.699474e-01 | 0.770 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 1.699474e-01 | 0.770 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 1.709018e-01 | 0.767 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.713804e-01 | 0.766 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 1.713804e-01 | 0.766 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.750710e-01 | 0.757 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.768361e-01 | 0.752 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.768361e-01 | 0.752 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.772366e-01 | 0.751 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.772366e-01 | 0.751 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.772366e-01 | 0.751 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.811693e-01 | 0.742 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.833217e-01 | 0.737 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 1.836963e-01 | 0.736 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.836963e-01 | 0.736 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 1.836963e-01 | 0.736 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.836963e-01 | 0.736 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 1.836963e-01 | 0.736 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.836963e-01 | 0.736 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.836963e-01 | 0.736 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.836963e-01 | 0.736 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.836963e-01 | 0.736 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.836963e-01 | 0.736 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 1.838757e-01 | 0.735 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.923695e-01 | 0.716 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 1.936371e-01 | 0.713 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.954126e-01 | 0.709 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.954126e-01 | 0.709 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.954126e-01 | 0.709 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.954126e-01 | 0.709 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.954126e-01 | 0.709 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.954126e-01 | 0.709 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.954126e-01 | 0.709 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.954126e-01 | 0.709 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.954126e-01 | 0.709 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.954126e-01 | 0.709 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.954126e-01 | 0.709 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.966021e-01 | 0.706 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.998298e-01 | 0.699 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.000015e-01 | 0.699 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.006274e-01 | 0.698 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.064496e-01 | 0.685 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.073740e-01 | 0.683 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.073740e-01 | 0.683 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.078553e-01 | 0.682 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.095343e-01 | 0.679 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.095343e-01 | 0.679 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.129786e-01 | 0.672 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.138057e-01 | 0.670 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.138057e-01 | 0.670 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.138057e-01 | 0.670 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.162347e-01 | 0.665 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.178742e-01 | 0.662 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.184589e-01 | 0.661 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 2.226471e-01 | 0.652 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.237648e-01 | 0.650 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.240901e-01 | 0.650 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 2.240901e-01 | 0.650 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.240901e-01 | 0.650 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.240901e-01 | 0.650 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.262685e-01 | 0.645 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.275529e-01 | 0.643 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.278781e-01 | 0.642 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.323501e-01 | 0.634 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.359164e-01 | 0.627 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.380268e-01 | 0.623 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.380268e-01 | 0.623 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.387365e-01 | 0.622 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 2.392806e-01 | 0.621 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.392806e-01 | 0.621 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.428489e-01 | 0.615 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.460591e-01 | 0.609 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.493185e-01 | 0.603 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.509858e-01 | 0.600 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.509858e-01 | 0.600 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.509858e-01 | 0.600 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.509858e-01 | 0.600 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.509858e-01 | 0.600 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.509858e-01 | 0.600 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.524231e-01 | 0.598 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.536790e-01 | 0.596 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.554559e-01 | 0.593 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.554559e-01 | 0.593 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.573765e-01 | 0.589 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.573765e-01 | 0.589 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.624874e-01 | 0.581 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.624874e-01 | 0.581 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.624874e-01 | 0.581 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.624874e-01 | 0.581 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.624874e-01 | 0.581 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.624874e-01 | 0.581 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.624874e-01 | 0.581 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.624874e-01 | 0.581 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 2.624874e-01 | 0.581 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.624874e-01 | 0.581 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.628306e-01 | 0.580 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.628306e-01 | 0.580 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.696586e-01 | 0.569 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.696586e-01 | 0.569 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.696586e-01 | 0.569 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.696586e-01 | 0.569 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.696586e-01 | 0.569 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.696586e-01 | 0.569 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.696586e-01 | 0.569 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.722115e-01 | 0.565 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.722193e-01 | 0.565 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.722193e-01 | 0.565 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.736227e-01 | 0.563 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.744987e-01 | 0.561 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 2.764307e-01 | 0.558 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.764307e-01 | 0.558 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.764307e-01 | 0.558 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.764307e-01 | 0.558 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.820974e-01 | 0.550 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.833714e-01 | 0.548 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.833714e-01 | 0.548 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.847911e-01 | 0.545 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.849923e-01 | 0.545 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 2.854509e-01 | 0.544 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.883192e-01 | 0.540 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.883192e-01 | 0.540 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.883192e-01 | 0.540 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.900976e-01 | 0.537 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.908111e-01 | 0.536 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.910027e-01 | 0.536 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.937177e-01 | 0.532 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.945901e-01 | 0.531 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.955055e-01 | 0.529 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 2.989867e-01 | 0.524 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 2.989867e-01 | 0.524 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.989867e-01 | 0.524 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 2.989867e-01 | 0.524 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.989867e-01 | 0.524 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.989867e-01 | 0.524 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.989867e-01 | 0.524 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.994881e-01 | 0.524 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.035717e-01 | 0.518 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 3.038109e-01 | 0.517 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.038109e-01 | 0.517 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.038109e-01 | 0.517 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.058639e-01 | 0.514 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.069231e-01 | 0.513 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.069231e-01 | 0.513 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.069231e-01 | 0.513 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.069231e-01 | 0.513 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.069231e-01 | 0.513 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.069231e-01 | 0.513 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.069231e-01 | 0.513 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.074930e-01 | 0.512 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.104666e-01 | 0.508 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.125168e-01 | 0.505 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.171816e-01 | 0.499 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.175513e-01 | 0.498 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.175513e-01 | 0.498 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.175513e-01 | 0.498 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.184648e-01 | 0.497 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.184648e-01 | 0.497 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.184648e-01 | 0.497 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.254303e-01 | 0.488 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.254303e-01 | 0.488 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 3.254303e-01 | 0.488 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.254303e-01 | 0.488 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.254303e-01 | 0.488 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.254303e-01 | 0.488 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 3.254303e-01 | 0.488 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.254303e-01 | 0.488 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.264982e-01 | 0.486 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.313001e-01 | 0.480 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.319554e-01 | 0.479 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.336818e-01 | 0.477 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.336818e-01 | 0.477 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 3.336818e-01 | 0.477 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.336818e-01 | 0.477 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.336818e-01 | 0.477 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.336818e-01 | 0.477 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.336818e-01 | 0.477 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.336818e-01 | 0.477 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 3.336818e-01 | 0.477 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.336818e-01 | 0.477 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 3.336818e-01 | 0.477 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 3.336818e-01 | 0.477 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.365523e-01 | 0.473 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.389437e-01 | 0.470 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.429740e-01 | 0.465 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.438050e-01 | 0.464 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 3.438050e-01 | 0.464 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 3.438050e-01 | 0.464 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.438050e-01 | 0.464 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.450397e-01 | 0.462 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.450397e-01 | 0.462 | 0 | 0 |
| Translation | R-HSA-72766 | 3.507396e-01 | 0.455 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.524007e-01 | 0.453 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.528908e-01 | 0.452 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.587534e-01 | 0.445 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.620148e-01 | 0.441 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 3.620148e-01 | 0.441 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.626774e-01 | 0.440 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.628203e-01 | 0.440 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.666618e-01 | 0.436 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.666618e-01 | 0.436 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.666618e-01 | 0.436 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.666618e-01 | 0.436 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.666618e-01 | 0.436 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.666618e-01 | 0.436 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 3.666618e-01 | 0.436 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.671969e-01 | 0.435 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 3.724251e-01 | 0.429 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.724251e-01 | 0.429 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.740568e-01 | 0.427 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.764223e-01 | 0.424 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.800313e-01 | 0.420 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 3.800313e-01 | 0.420 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 3.800313e-01 | 0.420 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.800313e-01 | 0.420 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.814067e-01 | 0.419 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.833962e-01 | 0.416 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.926196e-01 | 0.406 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 3.926196e-01 | 0.406 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.965360e-01 | 0.402 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.967556e-01 | 0.401 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 3.978289e-01 | 0.400 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.980112e-01 | 0.400 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.980112e-01 | 0.400 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.980112e-01 | 0.400 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.980112e-01 | 0.400 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.980112e-01 | 0.400 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 3.980112e-01 | 0.400 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.980112e-01 | 0.400 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.980112e-01 | 0.400 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.980112e-01 | 0.400 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.980112e-01 | 0.400 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.980112e-01 | 0.400 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.025353e-01 | 0.395 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.026171e-01 | 0.395 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.026171e-01 | 0.395 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.026171e-01 | 0.395 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.032535e-01 | 0.394 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.079306e-01 | 0.389 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.080572e-01 | 0.389 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.124321e-01 | 0.385 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 4.124321e-01 | 0.385 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.130434e-01 | 0.384 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 4.148228e-01 | 0.382 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.153852e-01 | 0.382 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.161023e-01 | 0.381 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.223042e-01 | 0.374 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.242650e-01 | 0.372 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.242650e-01 | 0.372 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.264063e-01 | 0.370 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.264063e-01 | 0.370 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.264063e-01 | 0.370 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.278107e-01 | 0.369 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.278107e-01 | 0.369 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.278107e-01 | 0.369 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.278107e-01 | 0.369 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.278107e-01 | 0.369 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.278107e-01 | 0.369 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.278107e-01 | 0.369 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.326806e-01 | 0.364 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.326806e-01 | 0.364 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.326806e-01 | 0.364 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.396608e-01 | 0.357 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.416728e-01 | 0.355 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 4.419523e-01 | 0.355 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.435565e-01 | 0.353 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.486667e-01 | 0.348 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.496979e-01 | 0.347 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.496979e-01 | 0.347 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.496979e-01 | 0.347 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.517176e-01 | 0.345 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.561368e-01 | 0.341 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.561368e-01 | 0.341 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.561368e-01 | 0.341 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.561368e-01 | 0.341 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.561368e-01 | 0.341 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.561368e-01 | 0.341 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.561368e-01 | 0.341 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.561368e-01 | 0.341 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.561368e-01 | 0.341 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.594171e-01 | 0.338 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.599594e-01 | 0.337 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.599594e-01 | 0.337 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.637667e-01 | 0.334 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.658024e-01 | 0.332 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.658024e-01 | 0.332 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.658024e-01 | 0.332 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 4.664221e-01 | 0.331 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 4.664221e-01 | 0.331 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 4.664221e-01 | 0.331 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.664221e-01 | 0.331 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.664221e-01 | 0.331 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.664221e-01 | 0.331 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.728723e-01 | 0.325 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.735038e-01 | 0.325 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.746981e-01 | 0.324 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.765600e-01 | 0.322 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.828408e-01 | 0.316 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.828408e-01 | 0.316 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.828408e-01 | 0.316 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.828408e-01 | 0.316 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.830623e-01 | 0.316 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.830623e-01 | 0.316 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.830623e-01 | 0.316 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.830623e-01 | 0.316 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 4.830623e-01 | 0.316 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.830623e-01 | 0.316 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.855520e-01 | 0.314 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.913908e-01 | 0.309 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.988130e-01 | 0.302 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.989431e-01 | 0.302 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.989431e-01 | 0.302 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.989431e-01 | 0.302 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 4.989431e-01 | 0.302 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.989431e-01 | 0.302 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.024629e-01 | 0.299 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.039566e-01 | 0.298 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.086563e-01 | 0.294 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.086563e-01 | 0.294 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.086563e-01 | 0.294 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.086563e-01 | 0.294 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.086563e-01 | 0.294 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.086563e-01 | 0.294 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.086563e-01 | 0.294 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.086563e-01 | 0.294 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.091798e-01 | 0.293 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.124273e-01 | 0.290 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.147201e-01 | 0.288 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.147201e-01 | 0.288 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.147201e-01 | 0.288 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.147201e-01 | 0.288 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.163604e-01 | 0.287 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.163604e-01 | 0.287 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.163604e-01 | 0.287 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.301647e-01 | 0.276 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.329846e-01 | 0.273 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.329846e-01 | 0.273 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.329846e-01 | 0.273 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.329846e-01 | 0.273 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.329846e-01 | 0.273 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.329846e-01 | 0.273 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.329846e-01 | 0.273 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.362594e-01 | 0.271 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.362594e-01 | 0.271 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.368403e-01 | 0.270 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.382982e-01 | 0.269 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.406565e-01 | 0.267 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.435447e-01 | 0.265 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.452709e-01 | 0.263 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.561097e-01 | 0.255 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.561097e-01 | 0.255 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.561097e-01 | 0.255 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.561097e-01 | 0.255 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.561097e-01 | 0.255 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.561097e-01 | 0.255 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.561097e-01 | 0.255 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.561097e-01 | 0.255 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.586221e-01 | 0.253 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.662312e-01 | 0.247 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.662312e-01 | 0.247 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.662312e-01 | 0.247 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.682217e-01 | 0.245 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.686010e-01 | 0.245 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.744525e-01 | 0.241 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.780910e-01 | 0.238 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.780910e-01 | 0.238 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.780910e-01 | 0.238 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.780910e-01 | 0.238 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.780910e-01 | 0.238 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.780910e-01 | 0.238 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.780910e-01 | 0.238 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.780910e-01 | 0.238 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.780910e-01 | 0.238 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.784534e-01 | 0.238 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.810641e-01 | 0.236 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.816488e-01 | 0.235 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.870592e-01 | 0.231 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.870592e-01 | 0.231 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.870592e-01 | 0.231 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.885227e-01 | 0.230 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.885227e-01 | 0.230 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.885227e-01 | 0.230 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.950339e-01 | 0.225 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.977668e-01 | 0.223 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.981802e-01 | 0.223 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.989851e-01 | 0.223 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.989851e-01 | 0.223 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.989851e-01 | 0.223 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.989851e-01 | 0.223 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.989851e-01 | 0.223 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.989851e-01 | 0.223 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.091033e-01 | 0.215 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.156172e-01 | 0.211 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.156172e-01 | 0.211 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.156172e-01 | 0.211 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.188457e-01 | 0.208 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.188457e-01 | 0.208 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.188457e-01 | 0.208 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.188457e-01 | 0.208 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.188457e-01 | 0.208 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.188457e-01 | 0.208 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.188457e-01 | 0.208 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.188457e-01 | 0.208 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.257206e-01 | 0.204 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.263756e-01 | 0.203 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.286425e-01 | 0.202 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.286425e-01 | 0.202 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.309310e-01 | 0.200 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.315037e-01 | 0.200 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.347593e-01 | 0.197 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.377238e-01 | 0.195 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.377238e-01 | 0.195 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.377238e-01 | 0.195 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.377238e-01 | 0.195 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.413216e-01 | 0.193 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.413216e-01 | 0.193 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.524084e-01 | 0.185 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.536570e-01 | 0.185 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 6.536570e-01 | 0.185 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.556680e-01 | 0.183 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.556680e-01 | 0.183 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.556680e-01 | 0.183 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 6.556680e-01 | 0.183 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.556680e-01 | 0.183 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.556680e-01 | 0.183 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.556680e-01 | 0.183 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.556680e-01 | 0.183 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 6.556680e-01 | 0.183 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.656515e-01 | 0.177 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.656515e-01 | 0.177 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.656515e-01 | 0.177 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.656515e-01 | 0.177 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 6.703930e-01 | 0.174 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.703930e-01 | 0.174 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 6.703930e-01 | 0.174 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.727244e-01 | 0.172 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.727244e-01 | 0.172 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.727244e-01 | 0.172 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.727244e-01 | 0.172 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.773087e-01 | 0.169 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.773087e-01 | 0.169 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.773087e-01 | 0.169 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.773087e-01 | 0.169 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.785298e-01 | 0.168 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.886325e-01 | 0.162 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.886325e-01 | 0.162 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.886325e-01 | 0.162 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.886325e-01 | 0.162 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.886325e-01 | 0.162 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.889369e-01 | 0.162 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.889369e-01 | 0.162 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.889369e-01 | 0.162 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.889369e-01 | 0.162 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.889369e-01 | 0.162 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 6.889369e-01 | 0.162 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.889369e-01 | 0.162 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.891866e-01 | 0.162 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.018616e-01 | 0.154 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.043472e-01 | 0.152 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.043472e-01 | 0.152 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.043472e-01 | 0.152 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.043472e-01 | 0.152 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.043472e-01 | 0.152 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.043472e-01 | 0.152 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.095895e-01 | 0.149 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.095895e-01 | 0.149 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.102980e-01 | 0.149 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.102980e-01 | 0.149 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.139553e-01 | 0.146 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.141597e-01 | 0.146 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.171703e-01 | 0.144 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.189950e-01 | 0.143 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.189950e-01 | 0.143 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.189950e-01 | 0.143 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.189950e-01 | 0.143 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.189950e-01 | 0.143 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.206497e-01 | 0.142 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.206497e-01 | 0.142 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.206497e-01 | 0.142 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.206497e-01 | 0.142 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 7.243342e-01 | 0.140 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.276042e-01 | 0.138 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.276653e-01 | 0.138 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.306877e-01 | 0.136 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.306877e-01 | 0.136 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.318857e-01 | 0.136 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.326196e-01 | 0.135 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.329179e-01 | 0.135 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.329179e-01 | 0.135 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.329179e-01 | 0.135 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.329179e-01 | 0.135 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 7.329179e-01 | 0.135 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.390348e-01 | 0.131 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 7.390348e-01 | 0.131 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.407075e-01 | 0.130 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.461518e-01 | 0.127 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.461518e-01 | 0.127 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.532401e-01 | 0.123 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 7.571628e-01 | 0.121 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 7.571628e-01 | 0.121 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.587307e-01 | 0.120 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.587307e-01 | 0.120 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.587307e-01 | 0.120 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.587307e-01 | 0.120 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.587307e-01 | 0.120 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.587307e-01 | 0.120 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.587307e-01 | 0.120 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.595958e-01 | 0.119 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.635223e-01 | 0.117 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.678193e-01 | 0.115 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.704071e-01 | 0.113 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.706870e-01 | 0.113 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.706870e-01 | 0.113 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.706870e-01 | 0.113 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.706870e-01 | 0.113 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.706870e-01 | 0.113 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.706870e-01 | 0.113 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.752764e-01 | 0.111 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.763776e-01 | 0.110 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.820514e-01 | 0.107 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.820514e-01 | 0.107 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 7.846586e-01 | 0.105 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.882054e-01 | 0.103 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.924298e-01 | 0.101 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.928534e-01 | 0.101 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.928534e-01 | 0.101 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.928534e-01 | 0.101 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.928534e-01 | 0.101 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.928534e-01 | 0.101 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.928534e-01 | 0.101 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.928534e-01 | 0.101 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.933820e-01 | 0.101 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.986926e-01 | 0.098 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.031206e-01 | 0.095 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.031206e-01 | 0.095 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.079031e-01 | 0.093 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.128794e-01 | 0.090 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.128794e-01 | 0.090 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.128794e-01 | 0.090 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.128794e-01 | 0.090 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.128794e-01 | 0.090 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.128794e-01 | 0.090 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 8.139807e-01 | 0.089 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.192219e-01 | 0.087 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.221321e-01 | 0.085 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.221552e-01 | 0.085 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.221552e-01 | 0.085 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.221552e-01 | 0.085 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.221552e-01 | 0.085 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.221552e-01 | 0.085 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.309716e-01 | 0.080 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.309716e-01 | 0.080 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.309716e-01 | 0.080 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.309716e-01 | 0.080 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.393515e-01 | 0.076 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.393515e-01 | 0.076 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.393515e-01 | 0.076 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.393515e-01 | 0.076 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.393515e-01 | 0.076 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.399372e-01 | 0.076 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.417043e-01 | 0.075 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.458267e-01 | 0.073 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.473165e-01 | 0.072 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.473165e-01 | 0.072 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.536459e-01 | 0.069 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.536459e-01 | 0.069 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.548869e-01 | 0.068 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.593035e-01 | 0.066 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.594623e-01 | 0.066 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.620825e-01 | 0.064 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.620825e-01 | 0.064 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.620825e-01 | 0.064 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.620825e-01 | 0.064 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.660352e-01 | 0.062 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.689217e-01 | 0.061 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.689217e-01 | 0.061 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.689217e-01 | 0.061 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.689217e-01 | 0.061 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.689217e-01 | 0.061 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.700224e-01 | 0.060 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.700224e-01 | 0.060 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.700224e-01 | 0.060 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.700224e-01 | 0.060 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.754221e-01 | 0.058 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.754221e-01 | 0.058 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.754221e-01 | 0.058 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.754221e-01 | 0.058 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 8.754221e-01 | 0.058 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.754221e-01 | 0.058 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.816005e-01 | 0.055 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.874729e-01 | 0.052 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.874729e-01 | 0.052 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.930543e-01 | 0.049 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.930543e-01 | 0.049 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.930543e-01 | 0.049 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.936144e-01 | 0.049 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.975422e-01 | 0.047 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.983593e-01 | 0.047 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.034014e-01 | 0.044 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.034014e-01 | 0.044 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.035439e-01 | 0.044 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.057925e-01 | 0.043 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.057925e-01 | 0.043 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.078550e-01 | 0.042 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.078550e-01 | 0.042 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.081936e-01 | 0.042 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.081936e-01 | 0.042 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.081936e-01 | 0.042 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.095536e-01 | 0.041 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.127484e-01 | 0.040 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.127484e-01 | 0.040 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.141982e-01 | 0.039 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.170775e-01 | 0.038 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.170775e-01 | 0.038 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.170775e-01 | 0.038 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.170775e-01 | 0.038 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.170775e-01 | 0.038 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.192380e-01 | 0.037 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.201236e-01 | 0.036 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.211920e-01 | 0.036 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.251026e-01 | 0.034 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.251026e-01 | 0.034 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.288194e-01 | 0.032 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.321899e-01 | 0.030 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.323520e-01 | 0.030 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.357094e-01 | 0.029 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.357094e-01 | 0.029 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.358676e-01 | 0.029 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.401502e-01 | 0.027 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.419332e-01 | 0.026 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.476996e-01 | 0.023 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.526334e-01 | 0.021 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.549853e-01 | 0.020 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.557110e-01 | 0.020 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.589290e-01 | 0.018 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.613638e-01 | 0.017 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.619267e-01 | 0.017 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.623812e-01 | 0.017 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.629400e-01 | 0.016 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.647166e-01 | 0.016 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.651063e-01 | 0.015 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.651063e-01 | 0.015 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.668395e-01 | 0.015 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.669089e-01 | 0.015 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.682981e-01 | 0.014 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.682981e-01 | 0.014 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.684867e-01 | 0.014 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.697320e-01 | 0.013 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.700522e-01 | 0.013 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.729539e-01 | 0.012 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.729539e-01 | 0.012 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.740670e-01 | 0.011 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.750215e-01 | 0.011 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.755250e-01 | 0.011 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.790382e-01 | 0.009 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.810701e-01 | 0.008 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.820111e-01 | 0.008 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.820111e-01 | 0.008 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.820111e-01 | 0.008 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.829053e-01 | 0.007 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.829053e-01 | 0.007 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.845396e-01 | 0.007 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.845627e-01 | 0.007 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.853303e-01 | 0.006 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.853303e-01 | 0.006 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.855076e-01 | 0.006 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.867528e-01 | 0.006 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.869092e-01 | 0.006 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.873029e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.874116e-01 | 0.006 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.880376e-01 | 0.005 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.893631e-01 | 0.005 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.902671e-01 | 0.004 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.904166e-01 | 0.004 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.911331e-01 | 0.004 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.925520e-01 | 0.003 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.926263e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.927676e-01 | 0.003 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.928779e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.933363e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.935156e-01 | 0.003 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.945599e-01 | 0.002 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.947134e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.954579e-01 | 0.002 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.954643e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.956902e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.961087e-01 | 0.002 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.964574e-01 | 0.002 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.969859e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.978924e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.980973e-01 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.989078e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.990796e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.991361e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.994427e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.994427e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.996301e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.997711e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.997915e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998006e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.998159e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.998673e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998780e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.998973e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999571e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999685e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999802e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999881e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999912e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999930e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999961e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999970e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999972e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999994e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999998e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |